Boron complexation strategy for use in manipulating 1-acyldipyrromethanes

ABSTRACT

A method of making a metal complex comprises combining a 1-monoacyldipyrromethane with a compound of the formula R 1 R 2 MX, wherein M is boron, R 1  and R 2  are each independently organic substituents; and X is an anion leaving group; to produce a metal complex of the formula DMR 1 R 2  wherein DH is a 1-monoacyldipyrromethane. The methods and complexes are useful for the purification and synthesis of dipyrromethanes and porphyrins.

RELATED APPLICATIONS

This application is a continuation in part of U.S. patent application Ser. No. 10/872,321, filed Jun. 18, 2004, the disclosure of which is incorporated by reference herein in its entirety.

This application is related to U.S. patent application Ser. No. 10/164,181, filed Sep. 3, 2003, titled Facile Synthesis of 1,9-Diacyldipyrromethanes; and

-   -   Ser. No. 10/698,255, filed Oct. 31, 2003, titled Synthesis of         Phosphono-substituted Porphyrin Compunds for Attachment to Metal         Oxide Surfaces,     -   the disclosures of which are incorporated by reference herein in         their entirety.

This invention was made with Government support under grant number GM36238 from the National Institutes of Health. The United States government has certain rights to this invention.

FIELD OF THE INVENTION

This invention concerns methods and intermediates useful for the synthesis of 1-acyldipyrromethanes, along with methods of use thereof.

BACKGROUND OF THE INVENTION

Rational syntheses of a variety of porphyrinic compounds bearing diverse patterns of meso substituents have been developed recently. The porphyrinic compounds include porphyrins,¹⁻³ chlorins,⁴ corroles,⁵ and bilanes.⁶ The syntheses begin with dipyrromethanes (1), and, depending on desired substitution pattern, also employ 1-acyldipyrromethanes (2) and 1,9-diacyldipyrromethanes (3) (Chart 1).^(1,2) 1-Acyldipyrromethanes are readily prepared from the corresponding dipyrromethane, while 1,9-diacyldipyrromethanes can be prepared by 9-acylation of a 1-acyldipyrromethane or by 1,9-diacylation of a dipyrromethane. Although the acylation procedures work reasonably well, purification is difficult owing to the lack of crystallinity of the acyldipyrromethanes. Accordingly, the mixture containing the acyldipyrromethane is usually separated by chromatography, which can be tedious owing to the tendency of the acyldipyrromethanes to streak on chromatographic media.

One of our objectives over the past few years has been to increase the scale of porphyrin syntheses, which entails decreasing if not eliminating reliance on chromatography for purification. Toward this goal, we recently developed a simple procedure for isolating a 1,9-diacyldipyrromethane from the diacylation reaction mixture by forming a dialkyltin complex (Chart 2).⁷ Dipyrromethanes, 1-acyldipyrromethanes or 1,8-diacyldipyrromethanes did not give tin complexes. The tin complex of a 1,9-diacyldipyrromethane was hydrophobic and crystalline, greatly facilitating isolation. In addition, the tin complex readily underwent decomplexation upon treatment with dilute trifluoroacetic acid. The availability of the tin-complexation procedure has enabled routine synthesis of multigram quantities of 1,9-diacyldipyrromethanes.

SUMMARY OF THE INVENTION

We herein describe the development of a boron-complexation strategy for the isolation and purification of 1-acyldipyrromethanes formed upon acylation of dipyrromethanes. We also describe use of the 1-acyldipyrromethane-boron complexes in porphyrin-forming reactions following similar procedures employed with 1-acyldipyrromethanes. The ability to complex the 1-acyldipyrromethane greatly facilitates purification and enables synthesis of 1-acyldipyrromethanes at the multigram scale.

Thus, a first aspect of the present invention is a method of making a metal complex, comprising: (a) providing a 1-monoacyldipyrromethane; and then (b) combining (e.g., in a suitable solvent such as dichloromethane) said 1-monoacyldipyrromethane with a compound of the formula R¹R²MX, wherein M is boron, R¹ and R² are each independently organic substituents (preferably substituents in which M is coupled by covalent link to a carbon atom in the organic substituents); and X is an anion leaving group; to produce a metal complex of the formula DMR¹R² wherein DH is said 1-monoacyldipyrromethane.

A further aspect of the present invention is a 1-monoacyldipyrromethane-boron complex of the formula DMR¹R², wherein: DH is a 1-monoacyldipyrromethane, M is boron, and R¹ and R² are as described above, and in further detail below. The complex may be provided in solid form, including crystal solid form.

A further aspect of the present invention is a method of making a porphyrin, comprising: providing a 1-monoacyldipyrromethane-boron complex as described herein, and then reducing said 1-monoacyldipyrromethane in said complex without prior decomplexation of said boron to produce said porphyrin.

A further aspect of the present invention is a method of making a 1,9-diacyldipyrromethane metal complex, comprising: providing a 1-monoacyldipyrromethane-boron complex as described herein; and then acylating said 1-monoacyldipyrromethane in said complex at the 9 position. Acylating may be carried out by any suitable means, typically with an acylating agent such as an acid halide or active ester (e.g., a pyridyl thioate Mukaiyama reagent) in the presence of a Grignard reagent, and optionally a base to produce said 1,9-diacyldipyrromethane metal complex.

A further aspect of the present invention is a method of making a compound useful as a chlorin eastern half, comprising: providing a 1-monoacyldipyrromethane-boron complex as described above, and then halogenating (e.g., brominating) said 1-monoacyldipyrromethane in said complex at the 9 position to produce a 1-acyl-9-halodipyrromethane-boron complex useful as a chlorin eastern half.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an ORTEP drawing of the X-ray structure of a 1-acyldipyrromethane-boron complex of the present invention (compound 6a-BBN). The diethyl ether solvate molecule is also illustrated. All ellipsoids are contoured at the 50% level, and hydrogens are omitted for clarity.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention is explained in greater detail below. This description is not intended to be a detailed catalog of all the different ways in which the invention may be implemented, or all the features that may be added to the instant invention. For example, features illustrated with respect to one embodiment may be incorporated into other embodiments, and features illustrated with respect to a particular embodiment may be deleted from that embodiment. In addition, numerous variations additions to the various embodiments suggested herein will be apparent to those skilled in the art in light of the instant disclosure which do not depart from the instant invention. Hence, the following specification is intended to illustrate some particular embodiments of the invention, and not to exhaustively specify all permutations, combinations and variations thereof.

“Alkyl,” as used herein, refers to a straight or branched chain hydrocarbon containing from 1 to 10 or 20 carbon atoms, or more. Representative examples of alkyl include, but are not limited to, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, 3-methylhexyl, 2,2-dimethylpentyl, 2,3-dimethylpentyl, n-heptyl, n-octyl, n-nonyl, n-decyl, and the like, which may be substituted or unsubstituted.

“Aryl,” as used herein, refers to a monocyclic carbocyclic ring system or a bicyclic carbocyclic fused ring system having one or more aromatic rings. Representative examples of aryl include pyridyl, azulenyl, indanyl, indenyl, naphthyl, phenyl, tetrahydronaphthyl, and the like, which may in turn be substituted or unsubstituted.

“Acyl” is intended to mean a —C(O)—R group, where R is a suitable substituent such as H, alkyl or aryl, which may in turn be substituted or unsubstituted.

“Dipyrromethane” as used herein includes an unsubstituted or substituted dipyrromethane, which may be substituted one or more times at the 1, 2, 3, 5, 7, 8 or 9 positions with any suitable substituent such as halo, carbonyl, alkyl, fluoroalkyl including perfluoroalkyl, aryl (e.g., aryl at the 5 position; alkyl at the 1 and/or 9 position), fluoroaryl including perfluoroaryl, etc. Dipyrromethanes may be coupled to porphyrinic macrocycles at any suitable position on the dipyrromethanes, including the 1, 2, 3, 5, 7, 8, or 9 position.

“Hindered alkyl amine base” as used herein refers to an amine base containing bulky substituents, such as in triethylamine, diisopropylethylamine, and triphenylamine, and not as in propyl amine.

“Halo” as used herein refers to chloro, fluoro, bromo, or iodo.

“Active Ester” as used herein refers to a compound which may be used to acylate a dipyrromethane or 1-acyldipyrromethane. In general an active ester is a compound of the general formula RCOX, where X is a leaving group. Any suitable leaving group may be used, including but not limited to alkylthio, arylthio, acyloxy (i.e., (RCO)₂O, or acid anhydride), 2,4-dinitrophenyloxy, etc. Suitable leaving groups for active esters include but are not limited to thioesters such as 2-S-pyridyl thioates (Mukaiyama reagents).

“Vilsmeier reagent” as used herein refers to a composition comprised of a dialkylamide and POCl₃. The dialkylamide may be of the general formula RC(═O)NR′R′, where R is H, alkyl or aryl, and R′ is alkyl, an example of such a dialkylamide being N-acylmorpholide.

“Anion leaving group” as used herein may be any suitable anionic leaving group, including but not limited to Cl, Br, and OTF (or “triflate”, O₃SCF₃).

“Acid halide” as used herein refers to any acid halide suitable as an acylating agent, including but not limited to acid chlorides, acid fluoride, acid bromides, acid iodides, etc.).

“Acylating agent” as used herein refers to any suitable acylating agent, including but not limited to acid halides and active esters (e.g., acid anhydrides, Mukaiyama reagents, etc.).

“Grignard reagent” has its conventional meaning in the art and includes compounds of the general formula RMgX, where X is bromo, chloro, or iodo, preferably bromo, and R is alkyl or aryl, preferably ethyl, sec-butyl, or mesityl.

“Hindered Grignard reagent” refers to a Grignard reagent as described above in which R is a bulky group such as mesityl, or more generally a group of the formula:

wherein R¹, R² and R³ are each independently selected C₁-C₄ alkyl.

“Mukaiyama reagent” is described in further detail below.

“Eastern half” and “Western half” are as described in further detail below.

“Disilazane” as used herein refers to compounds of the formula:

wherein R¹ through R⁶ are each independently selected from the group consisting of alkyl (e.g., methyl, ethyl, propyl) and aryl (e.g., phenyl).

All United States Patent references cited herein are to be incorporated by reference herein in their entirety.

Starting material 1-monoacyldipyrromethanes. Starting materials for the methods described herein are generally prepared by acylating a dipyrromethane. As such the starting materials are typically provide in a crude form or mixture combined with other reaction reagents and products. Depending upon the end use planned for the product, the dipyrromethane may be substituted at the 5 position with H, alkyl, or aryl; or in other embodiments may be substituted at the 5 position with a substituent such as a dipyrromethane, porphyrin, dipyrrin, or diacyldipyrromethane (which substituent may be directly coupled at the 5 position or coupled by an intermediate linking group such as an alkyl or aryl group). Acylation of the dipyrromethane may be carried out in any of a variety of ways. In one embodiment, acylating carried out by reacting the dipyrromethane with a compound of the formula RCOX, where R is an organic substituent such as alkyl or aryl and X is halo, to form a mixed reaction product comprising a 1-monoacyldipyrromethane acylated at the 1 position with RCO—. In another embodiment, acylating is carried out by reacting the dipyrromethane with an acid chloride and a Grignard reagent to form the mixed reaction product comprising a 1-monoacyldipyrromethane. In another embodiment, acylating is carried out by reacting the dipyrromethane with an active ester to form the mixed reaction product comprising a 1-monoacyldipyrromethane. In another embodiment, acylating is carried out by reacting the dipyrromethane with a Vilsmeier reagent to form a mixed reaction product comprising a 1-monoacyldipyrromethane. See. e.g., D. Gryko et al., J. Porphyrins Phthalocyanines 7, 239-248 (2003).

Making 1-monoacyldipyrromethane metal complexes and separation of such complexes. As noted above, the present invention provides a method of making a metal complex, comprising: (a) providing a 1-monoacyldipyrromethane and then (b) combining (e.g., in a suitable solvent such as dichloromethane) said 1-monoacyldipyrromethane with a compound of the formula R¹R²MX, wherein M is boron, R¹ and R² are each independently organic substituents (preferably substituents in which M is coupled by covalent link to a carbon atom in the organic substituents); and X is an anion leaving group; to produce a metal complex of the formula DMR¹R², wherein DH is said 1-monoacyldipyrromethane. Illustrative organic substituents for R¹ and R² are alkyl, alkenyl, alkynyl, and aryl, each of which can be unsubstituted or substituted one or more times with a substituent selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylcarbonyl, alkylcarbonyloxy, alkylsulfinyl, alkylsulfonyl, alkylthio, halo, cyano, nitro, sulfo, oxo, formyl, azido, and carbamoyl.

In some embodiments of the foregoing, the combining step is carried out by combining a mixture such as a crude reaction mixture containing the 1-monoacyldipyrromethane as a reaction product, along with other undesired compounds, with the compound of the formula R¹R²MX. For example, the combining step may he carried out in a solution and said metal complex is solubilized or suspended in said solution, said method further comprising the steps of: (c) combining said metal complex with a hindered alkyl amine base in an organic solvent to form a solid (e.g., a crystal solid) comprising said metal complex; and then (d) separating the complex from the organic solvent by filtration, centrifugation, sedimentation, or any other suitable separation technique. The time and temperature of the combining step is not critical, but may for example be from 1 or 2 minutes to 24 hours in duration, and is most conveniently carried out for 10 minutes to two hours, at a temperature range of −20° C. to 50 or 100° C. or more (e.g., room temperature). Any suitable organic solvent may be used, including but not limited to methylene chloride, chloroform, 1,2-dichloroethane, toluene, chlorobenzene, etc.

In some embodiments the method further comprises the step of: (c) decomplexing said 1-monoacyldipyrromethane from said metal complex by combining the metal complex with an hydroxide, an alcohol, water, or combination thereof. Typical sources of hydroxide include but are not limited to KOH, NaOH, LiOH, Ba(OH)₂, Mg(OH)₂, etc. Typical alcohols include but are not limited to methanol, neopentyl glycol, ethanolamine, polyethylene glycol, 1,3-propanediol, pentaerythritol, and polyvinyl alchol. Smooth decomplexation is obtained in refluxing solvents composed of water and tetrahydrofuran or alcohol and tetrahydrofuran. Decomplexation can be carried out in solution or with the hydroxy group that is coupled to (e.g., covalently coupled to) a solid support such as a solid support in accordance with known techniques.

In some embodiments, the compound of formula R¹R²MX may be immobilized on a solid support such as a polymer support, where the groups R constitute a portion of the polymer or are otherwise coupled to the polymer (with immobilization on the solid support facilitating the subsequent separation of the acylated dipyrromethane product). Hence the method further comprises the step of: (c) releasing said 1-monoacyldipyrromethane complex from said solid support, which releasing may be carried out utilizing the decomplexing procedures described above.

Thus the present invention provides a 1-monoacyldipyrromethane-boron complex of the formula DMR¹R², wherein: DH is a 1-monoacyldipyrromethane, M is boron, and R¹ and R² are as described herein. The complex may be provided in solid form, including crystal solid form.

Direct synthesis of porphyrins. Among other things the present invention provides a method of making a porphyrin, comprising: providing a 1-monoacyldipyrromethane-boron complex as described herein, and then reducing said 1-monoacyldipyrromethane in the complex without prior decomplexation of said boron to produce said porphyrin. In some embodiments the reducing step is carried out with NaBH₄ in an organic solvent.

Making 1,9-diacyldipyrromethanes and porphyrins therefrom. A further aspect of the present invention is a method of making a 1,9-diacyldipyrromethane metal complex, comprising: providing a 1-monoacyldipyrromethane-boron complex as described herein; and then acylating said 1-monoacyldipyrromethane in said complex at the 9 position with an acylating agent such as an acid halide or active ester (e.g. or a pyridyl thioate Mukaiyama reagent) in the presence of a Grignard reagent and a base to produce said 1,9-diacyldipyrromethane metal complex. Preferably the conjugate acid of said base has a pK_(a) greater than that of the conjugate acid of the nonacylated pyrrole group in said 1-monoacyldipyrromethane; thus the conjugate acid of the base typically has a pK_(a) greater than 17. When the base is formed in situ (in which case at least a second equivalent of the Grignard reagent is typically required), the conjugate acid of the base preferably has a pK_(a) less than that of the conjugate acid of the Grignard reagent (for example, a pK_(a) less than 45). When the base is preformed and not formed in situ the pK_(a) of the conjugate acid thereof may be greater, e.g., 50 or 60. The base may be the deprotonated form of a tetraalkylpiperidine (where said alkyl may be C1 to C4 alkyl, such as tetramethylpiperidine), dicycloalkylamine (where said alkyl may be C4 to C8 alkyl, such as dicyclohexylamine), or disilazane (as described above), accompanied by a cation such as K⁺, Na⁺, Rb⁺, Cs⁺, Ca²⁺, Be²⁺, Zn²⁺, Al³⁺, etc., preferably Li⁺ and Mg²⁺, most preferably Mg²⁺. Preferred bases are compounds of the formula XMZ, where X is a disilazane as described above in deprotonated form, M is a cation as described above, and Z if present is alkyl, halo, or other anion for charge balance. Suitable Grignard reagents are known in the art, are described above, and are also described in, among other references, U.S. Pat. Nos. 6,617,282, 6,608,212, 6,603,000 and 6,600,040. The Mukaiyama reagent is, in general, any suitable Mukaiyama reagent, typically a 2-S-pyridyl thioate. The reaction may be carried out in any suitable (preferably non-aqueous) organic solvent, such as an ethereal solvent such as tetrahydrofuran (THF) at a temperature of from −78° C. to 100° C. and any suitable pressure, and is preferably carried out at room temperature under ambient pressure.

Where no base is used for 9 acylation and 2 equivalents of ethyl magnesium bromide (Grignard reagent) is used (in which case one equivalent of the Grignard reagent serves as the base), the results are not so good. However, if two equivalents of a hindered Grignard reagent, such as mesityl-MgBr, are used, the 9-acylation results are excellent, regardless of whether a base such as a disilazane base is present. Evidently, mesityl-MgBr is a more hindered base than that formed with a disilazane, and provides even better results than the disilazane.

1,9-diacyldipyrromethanes produced in metal complexes as described above may in turn be reduced, while still within the metal complex, with a reducing agent (e.g. NaBH₄) to form a diol from the 1,9-diacyldipyrromethane in the complex, and the diol then condensing with a dipyrromethane in accordance with known techniques to form a porphyrin ring compound therefrom.

In some embodiments of the foregoing, the method further comprises the step of decomplexing the 1,9-diacyldipyrromethane from said metal complex by combining the metal complex with an hydroxide, an alcohol, water, or combination thereof in essentially the same manner as described above.

In some embodiments, the present invention further provides a method of making a metal complex (typically to aid in purifying the 1,9-diacyldipyrromethanes), comprising: reacting a 1,9-diacyldipyrromethane with a compound of the formula R¹R²M′X′₂ in the presence of a base, where R¹ and R² are the same as given above, M′ is Sn, Si, Ge or Pb (preferably Sn), and X′ is halo (e.g., chloro, bromo, iodo), OAc (where OAc is acetate), acac (acetylacetonate) or OTf (where OTf is triflate), to form a metal complex of the general formula DM′R¹R², wherein DH₂ is the 1,9-diacyldipyrromethane. Suitable bases include but are not limited to triethylamine, tributylamine, N,N-diisopropylamine, 1,8-diazabicyclo[5.4.0]undec-7-ene (or “DBU”), 1,5-diazabicyclo[4.3.0]non-5-ene (or “DBN”), and 2,6,-di-tert-butylpyridine. Again the compound of formula R¹R²M′X′₂ may be free in the reaction solution or immobilized on a solid support such as a polymer support, where the groups R¹ and R² then constitute a portion of the polymer or are otherwise coupled to the polymer (with immobilization on the solid support facilitating the subsequent separation of the acylated dipyrromethane product).

Making chlorins. A further aspect of the present invention is a method of making a compound useful as a chlorin eastern half, comprising: providing a 1-monoacyldipyrromethane-boron complex as described above, and then halogenating (e.g., brominating) said 1-monoacyldipyrromethane in said complex at the 9 position to produce a 1-acyl-9-bromodipyrromethane boron complex useful as a chlorin eastern half, or substituting the 1-monoacyldipyrromethane at the 9 position with alkoxy or acetoxy as described in U.S. Pat. No. 6,559,374. Any halogenating agent may be used, including but not limited to N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, 1,3-dichloro-5,5-dimethylhydantoin, 1,3-dibromo-5,5-dimethylhydantoin, chlorine, bromine, and iodine. The reaction is preferably carried out at a temperature less than room temperature, most preferably 0 to −100° C., in any suitable solvent such as tetrahydrofuran, dioxane, diethyl ether or other ethereal solvents, but preferably THF. The method may then further comprise the steps of condensing said 1-acyl-9-halodipyrromethane boron complex (containing the eastern half) (particularly the reduction product, i.e., the carbinol, derived from the 1-acyl-9-substituted dipyrromethane boron complex) with a chlorin western half (typically in an organic solvent in the presence of an acid) to form a condensation product; and then oxidatively cyclizing said condensation product (typically in an organic solvent in the presence of a base, an oxidant and a metal salt) to produce a chlorin. The terms “Eastern half” and “Western half” are known in the art of chlorin chemistry; reactions for producing a chlorin from eastern and western halves are known in the art of chlorin chemistry, and can be carried out in accordance with known techniques or variations thereof which will be apparent to those skilled in the art given the present disclosure. See, e.g., U.S. Pat. No. 6,559,374 to Lindsey and Balasubramanian.

Utility. 1-Acyldipyrromethanes are essential intermediates in the synthesis of trans-A₂B₂, trans-AB₂C, cis-A₂B₂, cis-AB₂C, and ABCD porphyrins; diverse chlorins; A₂B, AB₂, and ABC corroles; and bilanes. The boron-complexation strategy provides a facile method for the isolation of a 1-acyldipyrromethane from the crude acylation mixture. The boron-complexation strategy can be used for the purification of a wide variety of 1-acyldipyrromethanes. The 1-acyldipyrromethane-boron complexes can be decomplexed to give the 1-acyldipyrromethanes in good to excellent yields. Alternatively, reduction of a 1-acyldipyrromethane-boron complex followed by self-condensation of the resulting dipyrromethane-carbinol affords the corresponding trans-A₂B₂ porphyrin. The ability to isolate and handle 1-acyldipyrromethanes as dialkylboron complexes should increase the scale of 1-acyldipyrromethane syntheses and facilitate the preparation of a wide variety of porphyrinic compounds.

1-Acyldipyrromethanes produced as described herein can be used as an intermediate for the production of a variety of useful compounds, such as 1,9-diacyldipyrromethanes, which are in turn useful for the production of compounds such as porphyrin ring compounds or porphyrinic macrocycles. The porphyrinic macrocycles are useful, among other things, for the production of polymers thereof which may be immobilized or coupled to a substrate and used as light harvesting rods, light harvesting arrays, and solar cells, as described for example in U.S. Pat. No. 6,407,330 to Lindsey et al. or U.S. Pat. No. 6,420,648 to Lindsey. Porphyrinic macrocycles are also useful immobilized to a substrate for making charge storage molecules and information storage devices containing the same. Such charge storage molecules and information storage devices are known and described in, for example, U.S. Pat. No. 6,208,553 to Gryko et al.; U.S. Pat. No. 6,381,169 to Bocian et al.; and U.S. Pat. No. 6,324,091 to Gryko et al. The porphyrinic macrocycle may comprise a member of a sandwich coordination compound in the information storage molecule, such as described in U.S. Pat. No. 6,212,093 to Li et al. or U.S. Pat. No. 6,451,942 to Li et al.

The present invention is explained in greater detail in the following non-limiting Examples.

EXPERIMENTAL 1

The synthesis of a 1-acyldipyrromethane (2) is achieved by treatment of a dipyrromethane (1) with EtMgBr in THF at room temperature followed by addition of a pyridyl thioester (5) in THF at −78° C.² The product mixture consists of unreacted dipyrromethane (1), the 1-acyldipyrromethane (2), and pyridyl thioester and/or other byproducts (Scheme 1). A suitable complexation aid for application to such a mixture should meet several criteria, including at least some of the following: (1) afford reaction with diverse 1-acyldipyrromethanes, (2) resist complex formation with other species in the reaction mixture, particularly the dipyrromethane, (3) yield a crystalline solid, (4) exhibit sufficient stability for routine handling, and (5) undergo decomplexation under mild conditions to liberate the 1-acyldipyrromethane in pure form.

A number of metal complexes of 2-acylpyrroles are known, as shown in Chart 3. Pyrrole-2-carboxaldehyde forms a stable coordination complex (A) in conjunction with acetylacetone and copper(II), nickel(II), palladium(II), or platinum(II).⁸ Pyrrole-2-carboxaldehyde and imino derivatives therefrom also form complexes with various metals or coordination centers (B,⁹ C,¹⁰ D,¹¹ E,¹⁰ and F¹²). We began our search for suitable metal complexes of 1-acyldipyrromethanes on the basis of the known complexes of 2-acylpyrroles. Note that 1-acyldipyrromethanes and 2-acylpyrroles each contain the same α-acylpyrrole motif.

Results and Discussion

Identification of Suitable 1-Acyldipyrromethane-Coordination Complexes. A variety of metal reagents were examined as potential complexation aids for 1-acyldipyrromethanes. The metals include Mg(OAc)₂.4H₂O, Sc(OTf)₃, TiF₄, MnCl₂, Mn(OAc)₂, FeBr₃, Fe(OAc)₂, Fe(acac)₃, Co(OAc)₂.4H₂O, Ni(OAc)₂.4H₂O, Cu(OAc)₂.H₂O, Zn(OAc)₂.2H₂O, GeI₄, MoCl₃, RuCl₃.H₂O, Pd(OAc)₂, Pd(CH₃CN)₂Cl₂, Ag(OTf), CdCl₂, InCl₃, In(OAc)₃, SnF₄, SbCl₅, TeCl₄, CeI₃, EuCl₃, Dy(OTf)₃, Yb(OTf)₃, Tl(OAc), and BiCl₃. The conditions employed treatment of a methanolic solution of 2a² (100 mM) with the metal reagent (50 mM) at room temperature for 1 h. Most of the reagents examined gave multiple components. A readily isolable complex was obtained only with Cu(OAc)₂.H₂O, affording Cu-2a as a green precipitate (Scheme 2). While the formation of Cu-2a was promising, copper was found to have three limitations as a complexing agent: (1) the Cu-2a complex underwent decomplexation upon silica TLC; (2) formation of the complex was quite substrate selective: a copper complex was obtained for 1-p-toluoyl-5-phenyldipyrromethane (2a) but not with 1-pentafluorobenzoyl-5-(pentafluorophenyl)dipyrromethane (2e)¹; and (3) the Cu-2a complex was an amorphous solid rather than a crystalline product.

1-Acyldipyrromethane-Boron Complexes. To meet the objectives of broad applicability and formation of crystalline products, we turned to investigate boron complexes. The first boron derivative of a dipyrromethane species apparently was reported by Treibs et al.¹³ who reacted BF₃-etherate with a dipyrrin to obtain a difluoroboron-dipyrrin complex. A wide variety of such difluoroboron-dipyrrin (BODIPY) derivatives have been prepared owing to their high fluorescence yields.¹⁴ The boron-difluoride complexes of dipyrrins are exceptionally resistant to decomplexation.¹³⁻¹⁵ 2-Ketopyrroles are also known to form stable boron-difluoride complexes (G, Chart 3).¹⁵ A dialkylboron complex of a 2-iminopyrrole also is known (H, Chart 3).¹⁶

We thought that boron complexes with B,B-dialkyl substituents might afford the appropriate balance of stability and susceptibility to decomplexation for our studies. A variety of compounds containing N-(dialkylboryl)pyrrole¹⁷⁻²⁵ or N-(diarylboryl)pyrrole²⁶ motifs have been prepared. Thus, reaction of 2a and Bu₂B-OTf in CH₂Cl₂ containing TEA at room temperature afforded the corresponding boron complex 6a-BBu₂ in 93% yield (Scheme 3). The boron complex was readily isolated by passage through a pad of silica. The generality of the complexation of 1-acyldipyrromethane 2a with various boron reagents was examined. The complex of 2a with 9-BBN gave an orange-yellow solid whereas the boron complex with dibutyl or dimethyl substituents gave an orange oil. On the other hand, no complex was obtained with BF₃.O(Et)₂ or B-bromocatechol borane. Owing to the high yield and formation of a crystalline product, we primarily used 9-BBN complexes for further study. Scheme 3

R₂B X Complex Yield Bu₂B OTf 6a-BBu₂ 93% Me₂B Br 6a-BMe₂ 91% 9-BBN OTf 6a-BBN 94% F₂B F 6a-BF₂  0% B-Catechol Br 6a-B(cat)  0%

The selectivity of boron complexation was examined next. Dipyrromethane 1a did not give a boron complex (TLC analysis). However, a trace amount of an oxidized derivative, tentatively assigned as dipyrrinato-boron complex 7, was observed. The reaction of 1,9-diacyldipyrromethane 3a¹ and Bu₂B-OTf in CH₂Cl₂ containing TEA at room temperature afforded the corresponding bis-boron complex 3a-(BBu₂)₂ (Scheme 4).

The generality of the complexation with 9-BBN-OTf was examined with various 1-acyldipyrromethanes (Scheme 5). The requisite 1-acyldipyrromethanes 2a,² 2d,⁷ 2e,¹ 2f,² 2g,¹ 2h,⁷ and 2i²⁷ are known compounds while 2b and 2c were prepared herein following the general method.² In each case, the resulting boron complex was hydrophobic and easily isolated by passage through a pad of silica. The complexation of 1-acyldipyrromethanes 2a-2d and 2g with 9-BBN-OTf gave 6a-BBN-6d-BBN and 6g-BBN in excellent yields (87-97%). The reaction of 2e or 2f with 9-BBN-OTf gave complete reaction (TLC analysis), but partial decomplexation occurred upon passage through a silica pad, affording a mixture of 2e and 6e-BBN or 2f and 6f-BBN. The instability of the bulky, mesityl-substituted complex 6f-BBN was circumvented by reaction of 2f with Bu₂B-OTf, which gave 6f-BBu₂ as a stable product in 89% yield. The same approach with the pentafluorophenyl-substituted 2e gave 6e-BBu₂, which was isolated in pure form by silica pad separation but underwent facile decomplexation to 2e upon further handling. Scheme 5

2 R¹ R² R₂B Product (Yield) 2a

9-BBN 6a-BBN (94%) 2b

9-BBN 6b-BBN (91%) 2c

9-BBN 6c-BBN (87%) 2d

9-BBN 6d-BBN (97%) 2e

9-BBN Bu₂B 6e-BBN^(a)6e-BBu₂ (97%) 2f

9-BBN Bu₂B 6f-BBN^(a)6f-BBu₂ (89%) 2g

9-BBN 6g-BBN (96%) 2h

9-BBN Bu₂B 6h-BBN (93%) 6h-BBu₂ (90%) 2i

9-BBN Bu₂B 6i-BBN^(a)6i-BBu₂ (89%) ^((a))The product partially decomplexed upon chromatography.

To check the effect of the presence of a single pentafluorophenyl group at the 5- or 1-position, boron complexation reactions of 2h and 2i were investigated. The reaction of 2h (5-pentafluorophenyl substituent) with 9-BBN-OTf or Bu₂B-OTf gave a stable complex (6h-BBN or 6h-BBu₂) in excellent yield. However, reaction of 2i (1-pentafluorobenzoyl substituent) with 9-BBN-OTf gave a complex (6i-BBN) that proved unstable whereas the reaction of 2i with 9-BBu₂-OTf gave 6i-BBu₂ in 89% yield. Thus, the presence of the pentafluorophenyl group is deleterious only at the 1-acyl position.

It is noteworthy that almost all 9-BBN complexes of 1-acyldipyrromethanes were solids (the all-pentyl 6c-BBN was the one exception). On the other hand, almost all dibutylboron complexes of 1-acyldipyrromethanes were oils (6f-BBu₂ was the one exception). Regardless of state, the complexes are yellow-orange whereas the uncomplexed 1-acyldipyrromethanes are off-white solids. The 1-acyldipyrromethane-boron complexes are stable to water and routine handling. Unlike 1-acyldipyrromethanes, the 1-acyldipyrromethane-boron complexes can be precipitated/crystallized from CH₂Cl₂/hexanes, are relatively non-polar, and do not streak upon chromatography.

Characterization. The spectral changes upon boron complexation of a 1-acyldipyrromethane include the presence of the characteristic absorption at ˜340-390 nm. The ¹H NMR spectra show (1) disappearance of the NH resonance of the acylpyrrole unit, (2) a ˜0.4 ppm upfield shift of the unsubstituted pyrrolic NH resonance, (3) a downfield shift of the meso-proton (˜0.2 ppm), and (4) a downfield shift of the β-protons (˜1 ppm) of the acylpyrrole. The ¹³C NMR spectra show the downfield shift of the carbonyl carbon (˜8 ppm). The ¹¹B NMR spectra of selected samples (6a-BBN-6d-BBN, and 6g-BBN) each showed a single peak at ˜13 ppm, relative to the ¹¹B standard, BF₃.O(Et)₂ (0 ppm). For comparison, the boron signal in the unacylated N-(9-borabicyclo[3.3.1]non-9-yl)pyrrole appears at 59.9 ppm.²³ The relative upfield shift of the acylated pyrrole is characteristic of organoboron species with coordination in the lone p orbital of the boron atom.²⁸ Elemental analyses for some of the boron complexes were satisfactory while others showed unsatisfactory results for carbon. This discrepancy may stem from solvent inclusion in the crystal lattice of the boron complexes. However, FABMS analyses of these complexes were satisfactory.

X-ray structural analysis was performed on 6a-BBN (FIG. 1). Complexation results in near coplanarity of the boron atom, α-carbonyl, and pyrrole unit. The C—O bond length (1.298 Å) is longer than for that in 2-benzoylpyrrole (1.234 Å),²⁹ suggesting some enolate character. At the same time, the C—C bond between the carbonyl carbon and the α-carbon of the acylpyrrole (1.402 Å) is significantly shorter than for that in 2-benzoylpyrrole (1.445 Å)²⁹ suggesting partial multiple bond character. Similar structural features were reported for the 2-ketopyrrole-BF₂ complex.¹⁵

Boron Complexation as a Purification Aid for 1-Acyldipyrromethanes. An integrated procedure consisting of 1-acylation and subsequent boron complexation was developed. The two steps are carried out as follows:

The dipyrromethane (1) is treated with 2.0 molar equiv of EtMgBr followed by 1.0 molar equiv of a Mukaiyama reagent³⁰ (5). The reaction mixture is quenched with aqueous NH₄Cl, and the organic layer is separated and concentrated, affording the crude product 2 (vide infra). Note that the use of boron complexation to isolate the 1-acyldipyrromethane enables use of a stoichiometric quantity of EtMgBr, rather than an excess as employed previously to ensure complete consumption of the Mukaiyama reagent.²

The residue (2) is dissolved in CH₂Cl₂ and treated with TEA and R₂B-OTf at room temperature for 1 h. Passage of the reaction mixture over a pad of silica using CH₂Cl₂/hexanes as eluant readily affords the boron complex.

In this manner, a series of dipyrromethanes (1a-f,³¹ 1g³²) was reacted with the appropriate Mukaiyama reagent (5a-e,² 5f³³) followed by boron complexation with Bu₂B-OTf or 9-BBN-OTf. The boron complexes of 2a-2c and 2f-2h were readily obtained in good yield (Scheme 6). Scheme 6

1 + 5 R¹ R² R₂B Product (Yield) 1a + 5a

9-BBN 6a-BBN (67%) 1b + 5a

9-BBN 6b-BBN (60%) 1c + 5f

9-BBN 6c-BBN (60%) 1d + 5b

9-BBN 6d-BBN (66%) 1f + 5d

Bu₂B 6f-BBu₂ (68%) 1g + 5e

9-BBN 6g-BBN (71%) 1e + 5a

9-BBN 6h-BBN (58%)

A slight modification to the general boron-complexation method was explored to further minimize use of chromatography. The modification entails use of a solvent for complexation that results in precipitation of the 1-acyldipyrromethane-boron complex. Thus, the reaction of 2a with 9-BBN-OTf in the presence of TEA in toluene afforded a precipitate, which largely consisted of 6a-BBN and the TfOH.TEA salt. Washing with water and methanol afforded the desired 1-acyldipyrromethane-boron complex 6a-BBN. This procedure was employed with 8.88 g of 2a, affording a precipitate (9.63 g, 52%) of analytically pure 6a-BBN. Silica pad separation of the filtrate afforded additional material (1.77 g), giving an overall yield of 62%. This procedure is well suited for synthesis at the multigram level. Note that no change in solvent was required for use with 2d; the boron complex 6d-BBN precipitated upon formation in CH₂Cl₂. Note that dipyrromethanes 1a-f were prepared by a streamlined procedure with minimal or no reliance on chromatography,³¹ and 1g was prepared herein by the same procedure; accordingly, the overall route to form a 1-acyldipyrromethane can now be implemented with limited or no use of chromatography.

Decomplexation of 1-Acyldipyrromethane-Boron Complex. A simple method for decomplexation of the 1-acyldipyrromethane-boron complexes was investigated using 6a-BBN as a test case. The cleavage of the B—N bond in alkyl or aryl amines has been achieved with acids,^(34,35) bases,³⁵ or ethanolamine.³⁵ The similar cleavage of N-(dialkylboron)pyrroles has been achieved with acids^(19,24) or ethanol.²⁴ Given the potential lability of the 1-acyldipyrromethane to acidic conditions, we focused on neutral reaction conditions. Smooth decomplexation was obtained in refluxing solvents composed of H₂O/THF or ROH/THF, where ROH is methanol, neopentyl glycol, ethanolamine, polyethylene glycol, 1,3-propanediol, pentaerythritol or polyvinyl alcohol. In many cases, isolation could be achieved in nearly pure form without chromatography. A key factor in choice of alcohol is to avoid chromatography altogether for separation of the 1-acyldipyrromethane and the derivative formed upon reaction of ROH and the dibutylboron or 9-BBN species. We found that 1-pentanol generally afforded superior results. Accordingly, treatment of 6a-BBN with excess 1-pentanol in refluxing THF for 1 h followed by solvent removal, trituration with hot hexanes for 5 min, and recrystallization/precipitation from CH₂Cl₂/hexanes afforded 2a in 83% yield (Scheme 7). Scheme 7

6_(a)-BR₂ R¹ R² R₂B Product (Yield) 6a-BBN

9-BBN 2a (83%) 6b-BBN

9-BBN 2b (81%) 6c-BBN

9-BBN 2c (82%) 6d-BBN

9-BBN 2d (80%) 6f-BBu₂

Bu₂B 2f (65%)

Application of these decomplexation conditions to 6a-BBN, 6b-BBN, and 6d-BBN afforded 2a, 2b, and 2d, respectively in excellent yields (Scheme 7). The boron complex 6f-BBu₂ was decomplexed with neat 1-pentanol at 80° C. for 1 h followed by the workup procedure described above. Decomplexation of 6c-BBN with 1-pentanol in THF at reflux for 1 h afforded 2c, which was isolated upon passage through a pad of alumina.

Use of 1-Acyldipyrromethane-Boron Complexes in Porphyrin Formation. The reduction of a 1-acyldipyrromethane affords the corresponding dipyrromethane-1-carbinol, which upon self-condensation and oxidation affords the trans-A₂B₂ porphyrin.^(2,33) The 1-acyldipyrromethane-boron complexes were examined as precursors to trans-A₂B₂ porphyrins, thereby avoiding the boron-decomplexation procedure. Thus, the boron complex 6a-BBu₂ was treated with NaBH₄ in THF/methanol for 40 min. TLC analysis indicated complete consumption of 6a-BBu₂ formation of a new polar spot. The reaction mixture was worked up in the standard way and the product was subjected to acid-catalyzed self-condensation [Yb(OTf)₃ in CH₂Cl₂]³³ followed by oxidation with DDQ. Porphyrin 8 was obtained in 26% yield (Scheme 8). The boron complex 6a-BBN was treated similarly, affording porphyrin 8 in 17% yield. In both cases, no other porphyrin species were observed upon LD-MS³⁶ analysis of the crude reaction mixtures. For comparison, the reaction of the uncomplexed 1-acyldipyrromethane 2a affords porphyrin 8 in 25% yield.³³

9-Acylation of 1-Acyldipyrromethane-Boron Complexes. The acylation of dipyrromethanes to form 1,9-diacyldipyrromethanes is an essential step in the rational synthesis of porphyrins. Dipyrromethanes with identical acyl groups at the 1- and 9-positions are key precursors to A₃B-, trans-A₂B₂-, and trans-AB₂C-porphyrins. Dipyrromethanes bearing two different acyl groups at the 1- and 9-positions are required precursors to cis-A₂B₂-, cis-A₂BC- and ABCD-porphyrins. Reaction of a 1-acyldipyrromethane (2) with EtMgBr and an acid chloride affords the 1,9-diacyldipyrromethane (3).¹ Other methods (Friedel-Crafts, Vilsmeier, benzoxathiolium salt) also have been examined for the 9-acylation of a 1-acyldipyrromethane.⁷ Regardless of synthetic method, purification of acyldipyrromethane is difficult because acyldipyrromethanes (2 or 3) typically streak extensively upon chromatography and give amorphous powders upon attempted crystallization.

While the 1-acylation of dipyrromethanes proceeds well with yields of ˜80-90%, the 9-acylation has proved more problematic and generally afforded yields of ≦60%. The difficulty with the second acylation, while puzzling, has led to use of a more potent acylating agent (e.g., an acid chloride) than the pyridyl thioate (Mukaiyama reagent)³⁷ employed for the 1-acylation. A more fundamental limitation stem from the requirement for the presence of a base to neutralize the HCl liberated upon acylation. In principle, 3 equiv of EtMgBr and 1 equiv of acid chloride are needed for the reaction, but in practice,¹ 6 equiv of EtMgBr and 3 equiv of acid chloride are employed. Attempts to use various bases other than EtMgBr have generally afforded little improvement in the yield of the 1,9-diacyldipyrromethane.

Here we describe our studies on the use of 1-acyldipyrromethane-BR₂ complexes as acylation substrates. 9-BBN complexes were chosen because of their high crystallinity, however other dialkylboron complexes also can be used. We chose the reaction of 6a-BBN and S-2-pyridyl 4-methylbenzothioate (5a) as a model system for optimization of conditions. Thus, a solution of 6a-BBN (0.10 mmol, 1.0 M) in toluene at room temperature was treated with EtMgBr (0.15 mmol) followed by 5a (0.10 mmol, 1.0 M) in toluene (0.1 mL) (Scheme 9).

TLC and ¹H NMR analysis indicated the presence of equal amounts (˜1:1) of the desired 1,9-diacyldipyrromethane-BR₂ complex (3a-BBN) and the starting 1-acyldipyrromethane-BR₂ complex (6a-BBN) (entry 1, Table 1). The yield was determined by ¹H NMR spectroscopic analysis of crude reaction samples by comparing the peak intensity for the H³ proton signals for 1,9-diacylated (˜6.46 ppm) and 1-acylated (˜6.41 ppm) dipyrromethane-BR₂ complexes (Chart 4).

The use of THF rather than toluene as a solvent improved the relative yield of the 1,9-diacyldipyrromethane-BR₂ complex (˜1.7:1.0; entry 2). Use of p-toluoyl chloride rather than the Mukaiyama reagent gave relatively little reaction (˜0.4:1.0; entry 3). Use of 1 equiv of EtMgBr reduced the yield of the 1,9-diacyldipyrromethane-BR₂ complex (˜11.1:1.0; entry 4). A limiting yield of 50% is expected considering that the liberated products (3a-BBN and pyridylthiol) are more acidic than the starting material (6a-BBN), causing decomposition of the 6a-BBN-MgBr complex. On the other hand, use of excess EtMgBr is expected to be ineffective owing to the competive reaction of the Grignard reagent with Mukaiyama reagent (entry 5), forming the ketone. Indeed, the Mukaiyama reagents were initially developed for the synthesis of ketones.³⁷ TABLE 1 Conditions for the 9-acylation of 1-acyldipyrromethanes Substrate Solvent EtMgBr^(a) RCOX^(b) Entry (cmpd, mmol) (mL) Base (mmol) (mmol) Temperature (mmol) Product:Substrate^(c) 1 6a-BBN, 0.10 Toluene (0.1) — 0.15 RT 0.10 1.0:1.0 2 6a-BBN, 0.10 THF (0.1) — 0.15 RT 0.10 1.7:1.0 3 6a-BBN, 0.10 THF (0.2) — 0.15 RT 0.11^(d) 0.4:1.0 4 6a-BBN, 0.10 THF (0.1) — 0.10 RT 0.10 1.1:1.0 5 6a-BBN, 0.10 THF (0.1) — 0.25 RT 0.10 1.0:1.0 6 6a-BBN, 0.10 THF (0.2) TMP (0.10) 0.20 0° C. → RT 0.10 2.1:1.0 7 6a-BBN, 0.10 THF (0.2) Dicyclohexylamine (0.10) 0.20 0° C. → RT 0.10 2.3:1.0 8 6a-BBN, 0.10 THF (0.2) HMDS (0.10) 0.20 0° C. → RT 0.10 4.0:1.0 9 2a, 0.10 THF (0.10) — 0.20 RT 0.20 0.3:1.0 10 2a, 0.10 THF (0.20) HMDS (1.0) 0.30 0° C. → RT 0.20 0.6:1.0 ^(a)EtMgBr was used as a 1.0 M solution in THF. ^(b)S-2-Pyridyl 4-methylbenzothioate (5a). ^(c)The ratio was determined by ¹H NMR spectroscopic analysis of crude reaction samples. ^(d)p-Toluoyl chloride instead of 5a.

To overcome these problems we considered using a base whose conjugate acid (Base-H) has higher pK_(a) than that of the liberated products (3a-BBN and pyridylthiol) and starting material 6a-BBN. Thus the requirement for the base strength is as follows Et-MgBr>Base-MgBr>pyrrole-MgBr>acylpyrrole-MgBr>pyridylthiolate-MgBr, where X-MgBr refers to the Grignard reagent formed from the conjugate base of the weak acid XH. In other words the conjugate acid of the base should have a pK_(a) greater than that of pyrrole (˜17.5) and less than that of ethane (˜45). In addition the base should be non-nucleophilic. For such non-nucleophilic bases, we examined 2,2,6,6-tetramethylpiperidine (TMP), dicyclohexylamine and 1,1,1,3,3,3-hexamethyldisilazane (HMDS), which have pK_(a) values³⁸ of 37, 36 and 26, respectively (entry 6-8). A significant improvement was obtained with use of 2,2,6,6-tetramethylpiperidine or dicyclohexylamine (˜2:1; entries 6 and 7). Even greater improvement was obtained with HMDS, which gave a 4:1 ratio of 1,9-diacyl to 1-acyldipyrromethane products (entry 8).

A comparative study with an uncomplexed 1-acyldipyrromethane was performed using similar conditions with and without additional base. Thus, a solution of 1-(p-toluoyl)-5-phenyldipyrromethane (2a) (0.10 mmol) in THF (0.1 mL, 1.0 M) at room temperature was treated with EtMgBr (0.20 mmol) followed by 5a (0.10 mmol) in THF (0.1 mL, 1.0 M). TLC and ¹H NMR analysis indicated the presence of the desired 1,9-diacyldipyrromethane (3a) and the starting 1-acyldipyrromethane (2a) in only a ˜0.3:1 ratio (entry 9, Table 1). The ratio of 1,9-diacyldipyrromethane (3a) to the starting 1-acyldipyrromethane (2a) was improved slightly (˜0.6:1) by treating 2a (0.10 mmol) in THF (0.1 mL) and HMDS (0.10 mmol) with EtMgBr (0.30 mmol) followed by addition of 5a (0.20 mmol) in THF (0.20 mL, 1.0 M) (entry 10, Table 1). While the addition of HMDS afforded an improvement in the yield, the presence of the non-nucleophilic buffering agent alone was insufficient to afford a high yield with the uncomplexed 1-acyldipyrromethane. The origin of the low yield of the reaction with the uncomplexed 1-acyldipyrromethane may stem from poor reactivity in an aggregate, or complexation of the two neighboring pyrrolic species in the 1-acyldipyrromethane. This procedure wherein a mixture of 1-acyldipyrromethane-BR₂ complex (6-BR₂) (1 equiv) and HMDS (1 equiv) is treated with EtMgBr (2 equiv) followed by addition of Mukaiyama reagent (5) (1 equiv) in THF affords a superior yield of the corresponding 1,9-diacyldipyrromethane-BR₂ complex (3-BR₂). Moreover, the method enables use of the more gentle Mukaiyama reagents rather than acid chlorides for acylation.

On the basis of these observations we propose the following mechanism. The 1-acyldipyrromethane-BR₂ complex (6-BR₂) in principle requires only 1 equiv of EtMgBr owing to the absence of the NH (i.e. the protection afforded by the R₂B entity) to form the pyrrole-MgBr species. A second equiv of EtMgBr is used to make the non-nucleophilic buffering agent Base-MgBr, the Grignard derivative of the base. The pyrrole-MgBr species then reacts with the Mukaiyama reagent to give the acylpyrrolic-MgBr and pyridylthiol as a byproduct. Base-MgBr then reacts with pyridylthiol to give pyridylthiolate-MgBr and Base-H again. Note that like EtMgBr, Base-MgBr might also exist in a Schlenk equilibrium. Indeed, it is known that the Grignard derivative of HMDS exists in a multimeric complex.³⁹

It is noteworthy that the requirement for the presence of a “buffering agent” is less onerous in the synthesis of acylpyrroles. Indeed, in Nicolaou's synthesis of 2-acylpyrroles using the pyrrolic Grignard reagent and a Mukaiyama reagent, six equivalents of the pyrrolic Grignard reagent were employed.⁴⁰ In those syntheses, the Mukaiyama reagent was the more valuable species. In the synthesis of 1,9-diacyldipyrromethanes, the 1-acyldipyrromethane is a valuable intermediate and not available in excess, but the Grignard reagent of HMDS provides a suitable buffering agent.

Use of 1,9-Diacyldipyrromethane-Boron Complexes for Porphyrin Formation. The 1,9-diacyldipyrromethane-boron complex 3a-BBN was examined as a precursor in a porphyrin-forming reaction. Thus, the boron complex 3a-BBN was treated with NaBH₄ in THF/methanol for 40 min. The reaction mixture was worked up in the standard way^(1,2) and the product was subjected to acid-catalyzed condensation with dipyrromethane 1a followed by oxidation with DDQ. The corresponding porphyrin 8 was obtained in 20% yield. No other porphyrin species were observed upon LD-MS analysis of the crude reaction mixture.

Bromination of a 1-Acyldipyrromethane-Boron Complex. 1-Bromo-9-acyldipyrromethanes are precursors for the synthesis of chlorin building blocks.⁴ A 1-bromo-9-acyldipyrromethane is prepared by bromination of a 1-acyldipyrromethane. Treatment of 6a-BBN with NBS in THF at −78° C. for 1 h afforded the desired 1-bromo-9-acyldipyrromethane as the 9-BBN complex 9a-BBN in 94% yield (Scheme 10).

Experimental Section:

Noncommercial Compounds: Dipyrromethanes 1a-1f were prepared as described in the literature and analyzed for purity by gas chromatography.³¹ 1-Acyldipyrromethanes 2a,² 2d,⁷ 2e,¹ 2f,² 2g,¹ 2h,⁷ 2i,²⁷ and 3a¹ and the Mukaiyama reagents 5a-5e,² and 5f³³ were prepared as described in the literature.

5-[4-(Trimethylsilylethynyl)phenyl]dipyrromethane (1 g). Following a standard procedure,³¹ a solution of 4-(trimethylsilylethynyl)benzaldehyde (7.00 g, 35.0 mmol) in pyrrole (347 mL) was degassed for 10 min. Then InCl₃ (1.11 g, 5.00 mmol) was added. The mixture was stirred at room temperature under argon. After 1.5 h, NaOH (6.00 g, 0.15 mol, 20-40 mesh beads) was added and the stirring was continued for an additional 45 min. The mixture was filtered and the filtrate was concentrated under high vacuum. The resulting oil was triturated with hexanes (50 mL), and the volatile components were evaporated. This procedure was repeated four times, affording a white solid. Crystallization from ethanol afforded off-white crystals (7.66 g, 69%): mp 122-123° C. (lit.³² 120° C.); ¹H NMR spectral data are consistent with reported values:³² ¹H NMR δ 0.26 (s, 9H), 5.45 (s, 1H), 5.88-5.92 (m, 2H), 6.13-6.19 (m, 2H), 6.67-6.71 (m, 2H), 7.14 (d, J=8.0 Hz, 2H), 7.42 (d, J=8.0 Hz, 2H), 7.83-7.90 (br, 2H); Anal. Calcd for C₁₈H₂₀N₂: C, 75.42; H, 6.96; N, 8.80. Found: C, 75.40; H, 6.88; N, 8.75.

1-(4-Methylbenzoyl)dipyrromethane (2b). Following a standard procedure² (but with a 500 mM solution of 1b rather than 1 M owing to limited solubility), a solution of 1b (0.731 g, 5.00 mmol) in THF (10 mL) at room temperature under argon was treated with EtMgBr (12.5 mL, 12.5 mmol, 1.0 M solution in THF) for 10 min. The solution was cooled to −78° C. Then a solution of 5a (1.15 g, 5.00 mmol) in THF (5.0 mL) was added. The reaction mixture was stirred at −78° C. for 10 min and at room temperature for 20 min. Standard workup and chromatography [silica, CH₂Cl₂/ethyl acetate (9:1)] afforded a pale brown solid (0.812 g, 62%): mp 172-174° C.; ¹H NMR δ 2.43 (s, 3H), 4.09 (s, 2H), 6.03-6.06 (m, 1H), 6.08-6.12 (m, 1H), 6.14-6.18 (m, 1H), 6.51-6.55 (m, 1H), 6.80-6.86 (m, 1H), 7.27 (d, J=8.0 Hz, 2H), 7.76 (d, J=8.0 Hz, 2H), 9.25-9.28 (br, 1H), 10.94-10.98 (br, 1H); ¹³C NMR δ 21.8, 26.8, 106.4, 108.3, 110.3, 117.7, 123.1, 128.2, 129.3, 130.7, 136.0, 141.2, 142.7, 185.6; Anal. calcd for C₁₇H₁₆N₂O: C, 77.25; H, 6.10; N, 10.60. Found: C, 76.52; H, 5.89; N, 10.33.

1-Hexanoyl-5-pentyldipyrromethane (2c). Following a standard procedure,² a solution of 1c (1.08 g, 5.00 mmol) in THF (5.0 mL) under argon at room temperature was treated with EtMgBr (12.5 mL, 12.5 mmol, 1.0 M solution in THF) for 10 min. The solution was cooled to −78° C. Then a solution of 5f (1.05 g, 5.00 mmol) in THF (5.0 mL) was added. The reaction mixture was stirred at −78° C. for 10 min and at room temperature for 20 min. Standard workup and chromatography [silica, CH₂Cl₂/ethyl acetate (9:1)] afforded a light yellow oil (0.986 g, 63%): ¹H NMR δ 0.81-0.90 (m, 6H), 1.22-1.37 (m, 10H), 1.68-1.76 (m, 2H), 2.00-2.06 (m, 2H), 2.74 (t, J=7.6 Hz, 2H), 4.05 (t, J=7.6 Hz, 1H), 6.02-6.06 (m, 1H), 6.08-6.14 (m, 2H), 6.64-6.68 (m, 1H), 6.88-6.91 (m, 1H), 8.94-8.98 (br, 1H), 10.16-10.20 (br, 1H); ¹³C NMR δ 14.1, 14.2, 22.7, 26.2, 27.7, 31.85, 31.87, 33.8, 38.1, 38.3, 105.0, 108.1, 108.5, 117.3, 119.5, 131.1, 133.0, 144.8, 191.9; Anal. calcd for C₂₀H₃₀N₂O: C, 76.39; H, 9.62; N, 8.91. Found: C, 76.15; H, 9.80; N, 8.77.

Screening Protocol for Metal Complexation of 1-Acyldipyrromethanes. A solution of 2a (0.017 g, 0.050 mmol) in methanol (0.5 mL) was treated with a solution of a metal reagent (0.025 mmol) in methanol (0.5 mL). The mixture was stirred at room temperature for 1 h. The reaction was monitored visually for precipitate formation. The reaction mixture was examined by TLC (silica, CH₂Cl₂/ethyl acetate, 9:1) and by absorption spectroscopy.

Bis[1-(4-methylbenzoyl)-5-phenyldipyrromethan-10-yl]copper(II) (Cu-2a). A solution of 2a (0.25 mmol, 85 mg) in methanol (2.5 mL) was treated with a warm solution of Cu(OAc)₂.H₂O (0.30 mmol, 26 mg) in methanol (1 mL). The mixture was stirred at room temperature for 20 min. The resulting precipitate was filtered. The filtered material was washed with methanol and dried in vacuo to afford a green powder (75 mg, 81%): Anal. calcd for C₄₆H₃₈CuN₄O₂: C, 74.42; H, 5.16; N, 7.55. Found: C, 73.93; H, 5.22; N, 7.40; λ_(abs) 380 nm.

10-(Dibutylboryl)-1-(4-methylbenzoyl)-5-phenyldipyrromethane (6a-BBu₂). A solution of 2a (0.340 g, 1.00 mmol) in CH₂Cl₂ (2 mL) was treated with TEA (0.335 mL, 2.40 mmol) followed by Bu₂B-OTf (2.00 mL, 2.00 mmol, 1.0 M in CH₂Cl₂). After 30 min, the mixture was passed through a pad of silica (4×8 cm) eluting with CH₂Cl₂. The product eluted as a fast-moving yellow band, which upon concentration afforded an orange oil (0.431 g, 93%): ¹H NMR δ 0.36-0.52 (m, 2H), 0.61 (t, J=7.2 Hz, 3H), 0.65-1.18 (m, 13H), 2.47 (s, 3H), 5.60 (s, 1H), 5.85-5.88 (m, 1H), 6.13-6.17 (m, 1H), 6.45 (d, J=4.0 Hz, 1H), 6.68-6.72 (m, 1H), 7.20-7.38 (m, 8H), 7.79-7.83 (br, 1H), 8.11 (d, J=8.0 Hz, 2H); ¹³C NMR δ 14.3, 14.4, 22.2, 22.6, 22.7, 26.17, 26.24, 27.1, 27.5, 44.2, 107.9, 108.8, 117.4, 117.8, 119.3, 127.3, 128.0, 128.77, 128.83, 129.98, 130.01, 132.2, 134.2, 141.5, 145.4, 150.1, 176.5; FABMS obsd 465.3074 [(M+H)⁺], calcd 465.3077 (C₃₁H₃₇BN₂O); Anal. calcd for C₃₁H₃₇BN₂O: C, 80.17; H, 8.03; N, 6.03. Found: C, 79.98; H, 8.06; N, 5.95; λ_(abs) 393 nm.

10-(Dimethylboryl)-1-(4-methylbenzoyl)-5-phenyldipyrromethane (6a-BMe₂). A solution of 2a (0.340 g, 1.00 mmol) in CH₂Cl₂ (2 mL) was treated with TEA (0.335 mL, 2.40 mmol) followed by Me₂B—Br (0.390 mL, 1.00 mmol). After 30 min, the mixture was passed through a pad of silica (4×8 cm) eluting with CH₂Cl₂. The product eluted as a fast-moving yellow band, which upon concentration afforded an orange oil (0.344 g, 91%): ¹H NMR δ 0.04 (s, 3H), 0.15 (s, 3H), 2.48 (s, 3H), 5.66 (s, 1H), 5.87-5.92 (m, 1H), 6.15-6.19 (m, 1H), 6.43 (d, J=4.0 Hz, 1H), 6.70-6.75 (m, 1H), 7.24-7.38 (m, 8H), 7.84-7.88 (br, 1H), 8.11 (d, J=8.0 Hz, 2H); ³C NMR δ 6.8, 22.1, 44.1, 107.9, 108.6, 117.5, 118.3, 119.3, 127.3, 128.1, 128.8, 128.9, 129.95, 129.99, 132.0, 133.1, 141.4, 145.5, 150.1, 176.1; FABMS obsd 381.2158 [(M+H)⁺], calcd 381.2138 (C₂₅H₂₅BN₂O); Anal. calcd for C₂₅H₂₅BN₂O: C, 78.96; H, 6.63; N, 7.37. Found: C, 78.66; H, 6.60; N, 7.28; λ_(abs) 393 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methylbenzoyl)-5-phenyldipyrromethane (6a-BBN). A solution of 2a (0.680 g, 2.00 mmol) in CH₂Cl₂ (4 mL) was treated with TEA (0.670 mL, 4.80 mmol) followed by 9-BBN-OTf (8.00 mL, 4.00 mmol, 0.5 M in hexanes). After 30 min, the mixture was passed through a pad of silica (4×8 cm) eluting with CH₂Cl₂. The product eluted as a fast-moving yellow band, which upon concentration afforded a yellow-orange solid (0.863 g, 94%): mp 187° C. (dec.); ¹H NMR δ 0.66-0.71 (m, 2H), 1.65-1.84 (m, 6H), 1.95-2.25 (m, 6H), 2.48 (s, 3H), 5.83-5.86 (m, 1H), 6.01 (s, 1H), 6.13-6.17 (m, 1H), 6.41 (d, J=4.0 Hz, 1H), 6.69-6.73 (m, 1H), 7.18 (d, J=8.0 Hz, 2H), 7.22-7.38 (m, 6H), 7.83-7.87 (br, 1H), 8.11 (d, J=8.0 Hz, 2H); ¹³C NMR δ 22.0, 23.8, 25.1, 25.9, 26.4, 30.5, 30.8, 34.48, 34.54, 44.7, 108.1, 108.5, 117.4, 118.2, 120.8, 127.0, 128.1, 128.4, 128.6, 129.7, 129.9, 132.3, 134.8, 142.1, 145.0, 151.9, 174.4; ¹¹B NMR δ 12.34; FABMS obsd 460.2674 [M⁺], calcd 460.2686 (C₃₁H₃₃BN₂O); Anal. calcd for C₃₁H₃₃BN₂O: C, 80.87; H, 7.22; N, 6.08. Found: C, 78.96; H, 7.13; N, 5.85; λ_(abs) 381 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methylbenzoyl)dipyrromethane (6b-BBN). Following the procedure for 6a-BBN, reaction of 2b (0.529 g, 2.00 mmol) afforded a yellow-orange solid (0.696 g, 91%): mp 147° C. (dec.); ¹H NMR δ 0.71-0.78 (m, 2H), 1.67-1.75 (m, 4H), 1.76-1.91 (m, 4H), 1.98-2.14 (m, 2H), 2.16-2.26 (m, 2H), 2.48 (s, 3H), 4.34 (s, 2H), 6.03-6.06 (m, 1H), 6.16-6.18 (m, 1H), 6.36 (d, J=4.0 Hz, 1H), 6.69-6.72 (m, 1H), 7.29 (d, J=4.0 Hz, 1H), 7.36 (d, J=8.0 Hz, 2H), 7.90-7.94 (br, 1H), 8.11 (d, J=8.0 Hz, 2H); ¹³C NMR δ 22.1, 24.0, 25.2, 26.8, 29.5, 31.5, 34.5, 107.1, 108.7, 117.5, 118.3, 120.7, 128.2, 128.7, 129.8, 129.9, 135.3, 145.0, 149.5, 174.1; ¹¹B NMR δ 12.74; FABMS obsd 384.2395 [M⁺], calcd 384.2373 (C₂₅H₂₉BN₂O); Anal. calcd for C₂₅H₂₉BN₂O: C, 78.13; H, 7.61; N, 7.29. Found: C, 78.17; H, 7.58; N, 7.09; λ_(abs) 380 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-hexanoyl-5-pentyldipyrromethane (6c-BBN). Following the procedure for 6a-BBN, reaction of 2c (0.529 g, 2.00 mmol) afforded an orange oil (0.758 g, 87%): ¹H NMR δ 0.55-0.64 (m, 2H), 0.82-0.94 (m, 6H), 1.19-1.54 (m, 12H), 1.62-1.91 (m, 8H), 1.96-2.17 (m, 6H), 2.81 (t, J=8.0 Hz, 2H), 4.43 (t, J=8.0 Hz, 1H), 6.03-6.06 (m, 1H), 6.13-6.17 (m, 1H), 6.39 (d, J=4.0 Hz, 1H), 6.62-6.67 (m, 1H), 7.05 (d, J=4.0 Hz, 1H), 7.76-7.80 (br, 1H); ¹³C NMR δ 14.1, 14.2, 22.5, 22.6, 22.7, 24.0, 25.0, 25.8, 26.3, 27.6, 30.7, 30.8, 31.5, 31.7, 32.2, 34.19, 32.22, 36.4, 39.2, 105.2, 108.5, 117.0, 117.57, 117.63, 133.5, 136.5, 154.8, 184.3; ¹¹B NMR δ 13.22; FABMS obsd 434.3481 [M⁺], calcd 434.3468 (C₂₈H₄₃BN₂O); Anal. calcd for C₂₈H₄₃BN₂O: C, 77.41; H, 9.98; N, 6.45. Found: C, 75.22; H, 9.90; N, 6.40; λabs 345 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methoxybenzoyl)-5-(4-methoxyphenyl)dipyrromethane (6d-BBN). Following the procedure for 6a-BBN, reaction of 2d (0.773 g, 2.00 mmol) afforded a yellow-brown solid (0.986 g, 97%): mp 72-73° C.; ¹H NMR δ 0.64-0.74 (m, 2H), 1.62-1.86 (m, 6H), 1.98-2.24 (m, 6H), 3.79 (s, 3H), 3.92 (s, 3H), 5.82-5.87 (m, 1H), 5.96 (s, 1H), 6.12-6.17 (m, 1H), 6.40 (d, J=4.0 Hz, 1H), 6.69-6.72 (m, 1H), 6.84 (d, J=8.0 Hz, 2H), 7.05 (d, J=8.0 Hz, 2H), 7.10 (d, J=8.0 Hz, 2H), 7.30 (d, J=4.0 Hz, 1H), 7.84-7.88 (br, 1H), 8.21 (d, J=8.0 Hz, 2H); ¹³C NMR δ 24.0, 25.2, 26.0, 26.5, 30.6, 30.9, 34.6, 34.7, 44.0, 55.4, 55.8, 107.9, 108.6, 114.0, 114.7, 117.4, 117.8, 120.5, 123.5, 129.6, 130.0, 133.0, 134.4, 134.5, 151.7, 158.6, 164.4, 173.8; ¹¹B NMR δ 12.69; FABMS obsd 506.2749 [M⁺], calcd 506.2741 (C₃₂H₃₅BN₂O₃); Anal. calcd for C₃₂H₃₅BN₂O₃: C, 75.89; H, 6.97; N, 5.53. Found: C, 74.75; H, 7.37; N, 5.01; λ_(abs) 388 nm.

10-(Dibutylboryl)-1-(pentafluorobenzoyl)-5-pentafluorophenyldipyrromethane (6e-BBu₂). Following the procedure for 6a-BBu₂, reaction of 2e (0.506 g, 1.00 mmol) afforded an orange oil (0.608 g, 97%): ¹H NMR δ 0.13-0.35 (m, 2H), 0.58-1.39 (m, 16H), 5.94 (s, 1H), 6.00 (s, 1H), 6.15-6.20 (m, 1H), 6.61 (d, J=4.0 Hz, 1H), 6.74-6.80 (m, 1H), 7.04-7.10 (m, 1H), 8.05-8.09 (br, 1H); ¹³C NMR δ 14.1, 14.3, 20.9, 21.4, 26.0, 26.2, 26.9, 27.4, 33.5, 33.9, 108.5, 109.2, 109.4, 111.3, 118.8, 119.6, 119.7, 119.8, 122.1, 122.3, 127.0, 136.9 (m), 138.0, 139.6 (m), 142.1 (m), 142.9 (m), 143.9 (m), 144.4 (m), 145.5 (m), 146.4 (m), 147.0 (m), 150.6, 166.0. This compound partially decomplexed to 2e upon handling due to exposure to moisture.

10-(Dibutylboryl)-1-(4-iodobenzoyl)-5-mesityldipyrromethane (6f-BBu₂). Following the procedure for 6a-BBu₂, reaction of 2f (0.494 g, 1.00 mmol) afforded a yellow-orange solid (0.548 g, 89%): mp 53-54° C.; ¹H NMR δ −0.25-−0.17 (m, 1H), 0.24-0.39 (m, 2H), 0.55-0.98 (m, 13H), 1.14-1.27 (m, 2H), 2.15 (s, 6H), 2.62 (s, 3H), 5.88 (s, 1H), 5.90-5.93 (m, 1H), 6.16-6.20 (m, 1H), 6.50 (d, J=4.0 Hz, 1H), 6.66-6.70 (m, 1H), 6.83 (s, 2H), 7.17 (d, J=4.0 Hz, 1H), 7.80-7.84 (br, 1H), 7.85-7.94 (m, 4H); ¹³C NMR δ 14.3, 14.5, 20.9, 21.2, 21.8, 26.1, 26.2, 27.3, 27.5, 40.1, 101.9, 108.0, 108.9, 116.8, 117.0, 122.8, 130.0, 130.1, 130.6, 130.9, 134.8, 135.3, 136.9, 137.2, 138.6, 153.0, 174.7; FABMS obsd 619.2390 [(M+H)⁺], calcd 619.2357 (C₃₃H₄₀BIN₂O); Anal. calcd for C₃₃H₄₀BIN₂O: C, 64.09; H, 6.52; N, 4.53. Found: C, 64.08; H, 6.62; N, 4.40; λ_(abs) 404 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-bromophenyl)-5-[4-(2-trimethylsilyl)ethynylphenyl]dipyrromethane (6g-BBN). Following the procedure for 6a-BBN, reaction of 2g (0.529 g, 2.00 mmol) afforded a yellow-orange solid (1.19 g, 96%): mp 172° C. (dec.); ¹H NMR δ 0.24 (s, 9H), 0.64-0.73 (m, 2H), 1.64-1.85 (m, 6H), 1.94-2.09 (m, 4H), 2.12-2.24 (m, 2H), 5.83 (s, 1H), 6.00 (s, 1H), 6.13-6.18 (m, 1H), 6.39 (d, J=4.0 Hz, 1H), 6.71-6.75 (m, 1H), 7.09 (d, J=8.0 Hz, 2H), 7.32 (d, J=4.0 Hz, 1H), 7.40 (d, J=8.0 Hz, 2H), 7.68-7.74 (m, 2H), 7.82-7.86 (br, 1H), 8.02-8.10 (m, 2H); ¹³C NMR δ 0.18, 23.8, 25.1, 25.9, 26.6, 30.7, 30.8, 34.6, 44.8, 94.7, 104.9, 108.4, 108.8, 117.9, 118.7, 121.6, 122.1, 128.4, 129.2, 129.7, 131.0, 131.7, 132.4, 132.6, 132.7, 135.1, 142.4, 152.5, 173.2; ¹¹B NMR δ 13.98; FABMS obsd 620.2057 [M⁺], calcd 620.2030 (C₃₅H₃₈BBrN₂OSi); Anal. calcd for C₃₅H₃₈BBrN₂OSi: C, 67.64; H, 6.16; N, 4.51. Found: C, 67.41; H, 6.26; N, 4.43; λ_(abs) 388 nm.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methylbenzoyl)-5-(pentafluorophenyl)dipyrromethane (6h-BBN). Following the procedure for 6a-BBN, reaction of 2h (0.430 g, 1.00 mmol) afforded a yellow-orange solid (0.512 g, 93%): mp 154-156° C. (dec.); ¹H NMR δ 0.58-0.64 (m, 1H), 0.68-0.74 (m, 1H), 1.58-1.85 (m, 6H), 1.94-2.24 (m, 6H), 2.50 (s, 3H), 5.79 (s, 1H), 6.12-6.18 (m, 1H), 6.30 (s, 1H), 6.60 (d, J=4.0 Hz, 1H), 6.62-6.68 (m, 1H), 7.38 (d, J=4.0 Hz, 1H), 7.39 (d, J=8.0 Hz, 2H), 7.75-7.78 (br, 1H), 8.15 (d, J=8.0 Hz, 2H); ¹³C NMR δ 22.2, 23.9, 25.1, 26.3, 27.2, 29.8, 31.3, 34.67, 34.71, 36.3, 106.9, 109.2, 117.4, 118.3, 120.56, 120.60, 120.64, 127.9, 129.6, 130.07, 130.14, 135.9, 136.8 (m), 139.4 (m), 142.0 (m), 144.4 (m), 145.8, 146.4, 146.9 (m), 175.9; FABMS obsd 550.2229 [M⁺], calcd 550.2215 (C₃₁H₂₈BF₅N₂O); Anal. calcd for C₃₁H₂₈BF₅N₂O: C, 67.65; H, 5.13; N, 5.09. Found: C, 68.05; H, 5.23; N, 4.92; λ_(abs) 377 nm.

10-(Dibutylboryl)-1-(4-methylbenzoyl)-5-(pentafluorophenyl)dipyrromethane (6h-BBu₂). Following the procedure for 6a-BBu₂, reaction of 2h (0.430 g, 1.00 mmol) afforded an orange oil (0.497 g, 90%): ¹H NMR δ 0.16-0.35 (m, 2H), 0.54-1.25 (m, 16H), 2.48 (s, 3H), 5.94-6.02 (m, 2H), 6.14-6.18 (m, 11H), 6.57 (d, J=4.0 Hz, 1H), 6.72-6.78 (m, 1H), 7.24 (d, J=4.0 Hz, 1H), 7.38 (d, J=8.0 Hz, 2H), 8.06-8.10 (br, 1H), 8.12 (d, J=8.0 Hz, 2H); ¹³C NMR δ 14.2, 14.4, 21.5, 21.8, 22.2, 26.1, 26.3, 27.1, 27.6, 33.7, 107.9, 109.0, 117.4, 118.3, 119.68, 119.72, 119.76, 127.7, 128.0, 130.1, 130.2, 135.0, 145.6, 146.1, 177.6; FABMS obsd 555.2627 [(M+H)⁺], calcd 555.2606 (C₃₁H₃₂BF₅N₂O); Anal. calcd for C₃₁H₃₂BF₅N₂O: C, 67.16; H, 5.82; N, 5.05. Found: C, 67.00; H, 5.78; N, 4.91; λ_(abs) 386 nm.

10-(Dibutylboryl)-1-(pentafluorobenzoyl)dipyrromethane (6i-BBu₂). Following the procedure for 6a-BBu₂, reaction of 2i (0.340 g, 1.00 mmol) afforded an orange oil (0.412 g, 89%): ¹H NMR δ 0.58-0.68 (m, 2H), 0.74-0.92 (m, 10H), 1.00-1.08 (m, 2H), 1.16-1.30 (m, 4H), 4.09 (s, 2H), 6.04-6.09 (m, 1H), 6.14-6.20 (m, 1H), 6.45 (d, J=4.0 Hz, 1H), 6.70-6.75 (m, 1H), 7.01-7.06 (m, 1H), 7.90-7.93 (br, 1H); ¹³C NMR δ 14.4, 22.0, 26.2, 27.3, 107.6, 109.1, 117.8, 120.21, 120.26, 120.30, 121.9, 126.9, 137.5, 152.1, 164.1; FABMS obsd 465.2179 [(M+H)⁺], calcd 465.2137 (C₂₄H₂₆BF₅N₂O); Anal. calcd for C₂₄H₂₆BF₅N₂O: C, 62.09; H, 5.64; N, 6.03. Found: C, 61.31; H, 5.63; N, 5.93; λ_(abs) 382 nm.

Acylation-Boron Complexation Procedure, Exemplified for 6a-BBN. A solution of EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) was added slowly to a solution of 1a (2.22 g, 10.0 mmol) in THF (10 mL) under argon. The resulting mixture was stirred at room temperature for 10 min, and then cooled to −78° C. A solution of S-2-pyridyl 4-methylbenzothioate (5a, 2.29 g, 10.0 mmol) in THF (10 mL) was added. The solution was stirred at −78° C. for 10 min, then warmed to room temperature. The reaction mixture was quenched by addition of saturated aqueous NH₄Cl (40 mL). The mixture was extracted with ethyl acetate (30 mL). The organic layer was washed (water and brine), dried (Na₂SO₄), and filtered. The filtrate was concentrated. The crude product (a red-orange oil) thus obtained was dissolved in CH₂Cl₂ (20 mL) and treated with TEA (3.35 mL, 24.0 mmol) followed by 9-BBN-OTf (40 mL, 20.0 mmol, 0.5 M in hexane) with stirring at room temperature. A precipitate formed which largely consisted of the salt of TEA and triflic acid. After 1 h, the mixture was poured onto a pad of silica (4×8 cm) eluting with CH₂Cl₂. The product eluted as a fast-moving yellow band, which upon concentration afforded a yellow-orange solid (3.12 g, 67%) with satisfactory characterization data (mp, ¹H NMR spectrum and FABMS) as reported above.

Note: The use of boron complexation to isolate the 1-acyldipyrromethane enables use of stoichiometric quantities of reagents rather than excess as employed previously. Thus, the 1-acylation of dipyrromethanes was conducted with slight modification to the standard procedure. Previously, 2.5 molar equiv of EtMgBr was used for the acylation of dipyrromethane (1) with 1.0 molar equiv of a Mukaiyama reagent (5) in order to avoid co-chromatography of the unreacted 5 and the product 2.² (The unreacted Mukaiyama reagent is consumed by EtMgBr, affording the ketone³⁰). Given that the 1-acyldipyrromethane is to be isolated as a boron complex, complete consumption of the Mukaiyama reagent is not necessary.

Scale-up Procedure. A solution of EtMgBr (80.0 mL, 80.0 mmol, 1.0 M in THF) was added slowly to a solution of 1a (8.88 g, 40.0 mmol) in THF (40 mL) under argon. The resulting mixture was stirred at room temperature for 10 min, and then cooled to −78° C. A solution of S-2-pyridyl 4-methylbenzothioate (5a, 9.16 g, 40.0 mmol) in THF (40 mL) was added. The solution was stirred at −78° C. for 10 min, then warmed to room temperature. The reaction mixture was quenched by addition of saturated aqueous NH₄Cl. The mixture was extracted with ethyl acetate. The organic layer was dried (Na₂SO₄) and filtered. The filtrate was concentrated. The crude product (a red-orange oil) thus obtained was dissolved in toluene (80 mL) and treated with TEA (13.4 mL, 96.0 mmol) followed by 9-BBN-OTf (160 mL, 80.0 mmol, 0.5 M in hexanes) with stirring at room temperature. A precipitate formed immediately, which largely consisted of the title compound and the salt of TEA and triflic acid. After 1 h, the mixture was filtered through a Buchner funnel using coarse filter paper. The filtered material was washed with water, washed with methanol, and then dried in vacuo to afford a yellow powder (9.63 g, 52%). The filtrate was concentrated and passed through a silica pad eluting with CH₂Cl₂/hexanes afforded 1.77 g of the title compound. The combined yield is 11.4 g (62%) and the characterization data are satisfactory (mp, ¹H NMR, ¹³C NMR and FABMS spectra) as reported above.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methylbenzoyl)dipyrromethane (6b-BBN). Following the acylation-complexation procedure, reaction of 1b (1.46 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5a (2.29 g, 10.0 mmol) afforded crude 2b. Boron complexation with TEA (3.35 mL, 24.0 mmol) and 9-BBN-OTf (40.0 mL, 20.0 mmol, 0.5 M in hexanes) in CH₂Cl₂ followed by passage through a pad of silica [CH₂Cl₂/hexanes (1:1)] afforded a solid which upon trituration with hexanes afforded yellow crystals (2.30 g, 60%) with satisfactory characterization data (mp, ¹H NMR, and elemental analysis) as reported above.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-hexanoyl-5-pentyldipyrromethane (6c-BBN). Following the acylation-complexation procedure, reaction of 1c (2.16 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5f (2.09 g, 10.0 mmol) afforded crude 2c. Boron complexation with TEA (3.35 ml, 24.0 mmol) and 9-BBN-OTf (40.0 mL, 20.0 mmol, 0.5 M in hexanes) in CH₂Cl₂ followed by passage through a pad of silica [CH₂Cl₂/hexanes (1:1)] afforded an orange oil (2.59 g, 60%) with satisfactory characterization data (¹H NMR and ¹³C NMR spectra and FABMS) as reported above.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methoxybenzoyl)-5-(4-methoxyphenyl) dipyrromethane (6d-BBN). Following the acylation-complexation procedure, reaction of 1d (2.45 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5b (2.45 g, 10.0 mmol) afforded crude 2d. Boron complexation with TEA (3.35 mL, 24.0 mmol) and 9-BBN-OTf (40.0 mL, 20.0 mmol, 0.5 M in hexanes) in CH₂Cl₂ afforded a yellow-orange precipitate. The precipitate was filtered and dissolved in 50 mL of CH₂Cl₂. The solution was washed with water and brine, dried (Na₂SO₄), and concentrated to dryness. The resulting yellow solid was stirred in Et₂O for 1 min, filtered, washed with Et₂O and hexanes, dissolved in 20 mL of CH₂Cl₂ and concentrated to dryness, affording yellow crystals (2.81 g, 56%). The filtrates (from reaction mixture and stirring in Et₂O) were combined, concentrated, and filtered through a pad of silica CH₂Cl₂/hexanes (1:1), affording additional product (0.52 g). The total yield is 3.33 g (66%) and the characterization data are satisfactory (mp, ¹H NMR, and elemental analysis) as reported above.

10-(Dibutylboryl)-1-(4-iodobenzoyl)-5-mesityldipyrromethane (6f-BBu₂). Following the acylation-complexation procedure, reaction of 1f (2.64 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5d (2.29 g, 10.0 mmol) afforded crude 2f. Boron complexation with TEA (3.35 mL, 24.0 mmol) and dibutylboron triflate (20.0 mL, 20.0 mmol, 1.0 M in CH₂Cl₂) in CH₂Cl₂ followed by passage through a pad of silica [CH₂Cl₂/hexanes (1:2)] afforded a golden-yellow amorphous powder (4.23 g, 68%) with satisfactory characterization data (mp, ¹H NMR, and elemental analysis) as reported above.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-bromobenzoyl)-5-[4-(trimethylsilylethynyl)phenyl]dipyrromethane (6g-BBN). Following the acylation-complexation procedure, reaction of 1g (3.18 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5e (2.93 g, 10.0 mmol) afforded crude 2g. Boron complexation with TEA (3.35 mL, 24.0 mmol) and 9-BBN-OTf (40.0 mL, 20.0 mmol, 0.5 M in hexanes) in CH₂Cl₂ followed by passage through a pad of silica [CH₂Cl₂/hexanes (1:1)] afforded orange-yellow crystals (4.38 g, 71%) with satisfactory characterization data (mp, ¹H NMR, and elemental analysis) as reported above.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(4-methylbenzoyl)-5-(pentafluorophenyl)dipyrromethane (6h-BBN). Following the acylation-complexation procedure, reaction of 1h (3.12 g, 10.0 mmol) with EtMgBr (20.0 mL, 20.0 mmol, 1.0 M in THF) followed by treatment with 5a (2.29 g, 10.0 mmol) afforded crude 2h. Boron complexation with TEA (3.35 mL, 24.0 mmol) and 9-BBN-OTf (40.0 mL, 20.0 mmol, 0.5 M in hexanes) in CH₂Cl₂ followed by passage through a pad of silica [CH₂Cl₂/hexanes (1:1)] afforded yellow crystals (3.17 g, 58%) with satisfactory characterization data (mp, ¹H NMR, and elemental analysis) as reported above.

Decomplexation Procedure, Exemplified for 6a-BBN→2a. A solution of 6a-BBN (0.230 g, 0.500 mmol) in THF (0.8 mL) was treated with 1-pentanol (0.2 mL). The reaction mixture was heated at reflux. After 1 h, TLC (silica/CH₂Cl₂) examination showed almost complete consumption of boron complex 6a-BBN. The mixture was concentrated to dryness and the resulting oily residue was treated with 5 mL of hexanes. The oil solidified upon standing for 5 min. The mixture was heated gently under reflux for 5 min (the solid dissolved completely). The mixture was cooled, affording a precipitate upon standing for a few hours. The solvent was decanted. The solid was dissolved in a minimal amount of CH₂Cl₂ (˜0.2 mL), and the title compound was precipitated upon addition of hexanes. The precipitate was collected and dried in vacuo to afford a dark-yellow powder (0.118 g, 66%). The hexanes solution was concentrated to half of the starting volume. The resulting precipitate was filtered, dissolved in a minimal volume of CH₂Cl₂ and precipitated upon addition of hexanes, affording an additional 0.030 g of title compound. The combined yield (0.148 g) is 83%: mp 64-65° C. (lit.² 70-72° C.); ¹H NMR (CDCl₃) δ 2.42 (s, 3H), 5.54 (s, 1H), 5.99 (s, 1H), 6.04-6.08 (m, 1H), 6.16-6.20 (m, 1H), 6.72 (s, 1H), 6.79-6.83 (m, 1H), 7.36-7.22 (m, 8H), 7.75 (d, J=8.0 Hz, 2H), 7.97-8.00 (br, 1H) 9.34-9.37 (br, 1H); FABMS obsd 340.1593 [M⁺], calcd 340.1576 (C₂₃H₂₀N₂O).

Notes: High ratios of 1-pentanol/THF can be used and result in faster reaction (20 min), but can cause interference upon crystallization. In most cases, it is important to remove 1-pentanol completely because of the high solubility of 1-acyldipyrromethanes in 1-pentanol.

1-(4-Methylbenzoyl)dipyrromethane (2b). Following the decomplexation procedure, a sample of 6b-BBN (0.74 g, 2.0 mmol) was dissolved in THF (3 mL) and 1-pentanol (1 mL) was added. The mixture was refluxed for 1 h, then concentrated and treated with 5 mL of hexanes. The resulting precipitate was filtered, washed with hexanes and dried under vacuo to give pale yellow crystals (0.43 g, 81%) with satisfactory characterization data (mp, ¹H NMR, and elemental analysis) as described above.

1-Hexanoyl-5-pentyldipyrromethane (2c). Following the decomplexation procedure, reaction of 6c-BBN (0.869 g, 2.00 mmol) with 1-pentanol (1.00 mL, 10.0 mmol) in THF at reflux afforded a crude product. The crude product was passed through a pad of alumina [CH₂Cl₂→CH₂Cl₂/ethyl acetate (4:1)]affording a light yellow oil (0.514 g, 82%) with satisfactory characterization data (¹H NMR, elemental analysis) as described above.

1-(4-Methoxybenzoyl)-5-(4-methoxyphenyl)dipyrromethane (2d). Following the decomplexation procedure, a suspension of 6d-BBN (1.01 g, 2.00 mmol) in THF (3.2 mL) and 1-pentanol (0.8 mL) was refluxed for 1.5 h. The mixture was concentrated and the residue was dissolved in a small volume of CH₂Cl₂ and treated with hexanes. An oily precipitate was formed. The solvent was decanted. The residue was dried under vacuum, washed thoroughly with hexanes and dried again to afford a pale brown amorphous powder (0.610 g, 78%): mp 58-61° C. (dec.) (lit.⁷ 113-114° C.). The ¹H NMR data and elemental analysis data were consistent with those for the same compound obtained by a different route.⁷

1-(4-Iodobenzoyl)-5-mesityldipyrromethane (2f). A sample of 6f-BBu₂ (1.24 g, 2.00 mmol) was dissolved in 1-pentanol (4.0 mL). The solution was heated at 70-80° C. After 1 h the mixture was concentrated and 20 mL of hexanes was added. The mixture was heated at reflux for 2 min, and then cooled to room temperature. After standing overnight at −15° C., the precipitate was collected, dissolved in a minimum volume of CH₂Cl₂, and precipitated with hexanes. The precipitate was collected and dried in vacuo to afford a dark powder (0.639 g, 65%): mp 166-170° C. (lit.² 163° C.). The ¹H NMR and elemental analysis data were consistent with those for the same compound obtained by a different route.²

5,10-Bis(4-methylphenyl)-15,20-diphenylporphyrin (8) from 6a-BBu₂. A sample of 1-acyldipyrromethane-boron complex 6a-BBu₂ (0.116 g, 0.250 mmol) was dissolved in dry THF/methanol (3:1, 6 mL) at room temperature in a round-bottomed flask fitted with a vented rubber septum and flooded with argon. The septum was removed as needed to add NaBH₄ (0.238 g, 6.25 mmol, 25 mol equiv) in small portions with rapid stirring. The progress of the reduction was monitored by TLC analysis [alumina, CH₂Cl₂/ethyl acetate (3:2)] of reaction aliquots. After the reaction was complete (about 40 min), the reaction mixture was poured into a stirred mixture of saturated aqueous NH₄C₁ and CH₂Cl₂. The organic phase was separated, washed with water, dried (Na₂SO₄), and concentrated under reduced pressure to yield the monocarbinol as a foamlike solid. To the flask containing the dipyrromethane-moncarbinol (0.250 mmol assuming quantitative reduction) was added reagent-grade CH₂Cl₂ (50 mL). The mixture was stirred for 5 min to achieve dissolution, and then Yb(OTf)₃ (0.010 g, 0.016 mmol, 0.32 mM) was added. The reaction was monitored by absorption spectroscopy [by injecting a 50 μL reaction aliquot into a solution of DDQ (300 μL, 0.01 M in toluene); then 50 μL of the resulting oxidized mixture was dissolved in CH₂Cl₂/EtOH (3:1, 3 mL), and the absorption spectrum was recorded]. After acid-catalyzed condensation for 60 min, DDQ (0.085 mg, 0.375 mmol) was added. The mixture was stirred at room temperature for 1 h. TEA was added and the entire reaction mixture was passed through a pad of silica and eluted with CH₂Cl₂ until the eluant was no longer purple. The resulting porphyrin-containing solution was concentrated by rotary evaporation to give a purple solid. The solid was triturated with methanol and dried in vacuo affording a crystalline purple solid (0.021 g, 26%). The characterization data (¹H NMR, LDMS, and UV-vis spectra) were consistent with the reported values.²

5,10-Bis(4-methylphenyl)-15,20-diphenylporphyrin (8) from 6a-BBN. Following the porphyrin formation procedure for 8 from 6a-BBu₂, reaction of 6a-BBN (0.460 g, 1.00 mmol) afforded a purple solid (0.054 g, 17%) with satisfactory characterization data (¹H NMR, LDMS, and UV-vis spectra).

10-(9-Borabicyclo[3.3.1]non-9-yl)-5-phenyl-1,9-di-p-toluoyldipyrromethane (3a-BBN). A suspension of 6a-BBN (460 mg, 1.0 mmol) in THF (1 mL) and 1,1,1,3,3,3-hexamethyldisilazane (208 μL, 1.0 mmol) was treated with EtMgBr (2.20 mL, 2.20 mmol, 1 M solution in THF). The mixture was stirred at room temperature for 10 min. Then a solution of S-2-pyridyl 4-methylbenzothioate (5a, 274 mg, 1.2 mmol, 1 M solution in THF) was added. The mixture was stirred at room temperature for 0.5 h, and then the mixture was quenched by addition of a half-saturated aqueous solution of NH₄Cl (10 mL). Et₂O (10 mL) was added. The organic layer was washed with a saturated aqueous solution of NaHCO₃ (5 mL) followed by brine (10 mL). The organic layer was dried (Na₂SO₄) and concentrated to dryness under vacuum. The resulting brown residue (expected yield from crude NMR was 86%) was treated with small amount of Et₂O (˜1-2 mL), affording a suspension consisting of a brown solution and a bright yellow powder. A small amount of n-hexanes was added (˜2-4 mL). The resulting mixture was filtered on a Buchner funnel. The precipitate thus obtained was washed with cold methanol (2 mL) to afford a yellow powder (392 mg, 68%): ¹H NMR δ 0.70-0.73 (m, 2H), 1.68-2.20 (m, 12H), 2.41 (s, 3H), 2.48 (s, 3H), 6.00-6.02 (m, 1H), 6.10 (s, 1H), 6.46 (d, J=4.5 Hz, 1H), 6.80-6.82 (m, 1H), 7.17-7.38 (m, 10H), 7.77 (d, J=8.4 Hz, 2H), 8.13 (d, J=8.1 Hz, 2H), 9.15 (brs, 1H); ¹³C NMR δ 21.8, 22.2, 23.9, 25.2, 26.2, 26.3, 30.7, 31.0, 34.5, 34.6, 45.0, 111.3, 118.5, 119.9, 120.7, 127.6, 128.1, 128.5, 129.0, 129.1, 129.2, 129.9, 130.0, 131.0, 135.2, 135.8, 140.4, 141.0, 142.5, 145.4, 150.0, 175.2, 184.3. Anal. calcd for C₃₉H₃₉BN₂O₂: C, 80.96; H, 6.79; N, 4.84. Found: C, 81.19; H, 6.96; N, 4.65.

Scale-up Procedure. 10-(9-Borabicyclo[3.3.1]non-9-yl)-5-phenyl-1,9-di-p-toluoyldipyrromethane (3a-BBN). A suspension of 6a-BBN (2.30 g, 5.0 mmol) in THF (5 mL) and HMDS (1.04 mL, 5.0 mmol) was treated with EtMgBr (10.0 mL, 10.0 mmol, 1 M solution in THF). The mixture was stirred at room temperature for 15 min. Then a solution of S-2-pyridyl 4-methylbenzothioate (5a, 1.26 g, 1.1 mmol, 1 M solution in THF) was added. The mixture was stirred at room temperature for 0.5 h. The mixture was quenched by addition of a half-saturated aqueous solution of NH₄Cl (50 mL). Et₂O (50 mL) was added. The organic layer was washed with aqueous NaHCO₃ (50 mL), water (50 mL) and brine (50 mL). The organic layer was dried (Na₂SO₄) and concentrated to dryness under vacuum. The resulting brown residue was treated with small amount of Et₂O (˜5-10 mL), affording a suspension consisting of a brown solution and a bright yellow powder. A small amount of n-hexane was added (˜10 mL). The resulting mixture was filtered on a Buchner funnel. The precipitate thus obtained was further washed with a small amount of n-hexanes (˜10-20 mL) to afford a yellow powder (1.99 g, 69%): ¹H NMR δ 0.68-0.74 (m, 2H), 1.66-2.28 (m, 12H), 2.42 (s, 3H), 2.48 (s, 3H), 6.00-6.02 (m, 1H), 6.11 (s, 1H), 6.46 (d, J=4.4 Hz, 1H), 6.81 (dd, J=4.0 Hz, J=2.4 Hz, 1H), 7.18 (d, J=8.0 Hz, 2H), 7.25-7.38 (m, 8H), 7.77 (d, J=8.4 Hz, 2H), 8.13 (d, J=8.1 Hz, 2H), 9.18 (brs, 1H); ¹³C NMR δ 21.8, 22.2, 23.9, 25.2, 26.2, 26.3, 30.8, 31.0, 34.6, 34.7, 45.1, 127.6, 128.2, 128.5, 129.1, 129.2, 129.3, 130.0, 130.1, 131.2, 135.3, 135.9, 140.5, 141.0, 142.5, 145.4, 150.1, 175.2, 184.3; FABMS obsd 579.3176 [(M+H)⁺], calcd 579.3183 (C₃₉H₃₉BN₂O₂); Anal. calcd for C₃₉H₃₉BN₂O₂: C, 80.96; H, 6.79; N, 4.84. Found: C, 80.54; H, 6.70; N, 4.83.

An additional quantity of product was isolated from the filtrate as a tin complex as follows. The filtrate was concentrated to dryness. The resulting brown oily residue (˜830 mg) was dissolved in THF (2.4 mL) and treated with n-pentanol (0.6 mL). The reaction was heated at reflux. After 1 h, TLC (silica, CH₂Cl₂) examination showed complete consumption of the boron complex. The mixture was concentrated to dryness and the resulting dark brown oily residue was treated with TEA (0.42 mL, 3.0 mmol) and Bu₂SnCl₂ (0.30 g, 1.0 mmol) in CH₂Cl₂ (10 mL) at room temperature for 30 min. The mixture was passed through a silica pad (CH₂Cl₂). The eluant was concentrated to dryness. The residue was dissolved in a minimum amount of Et₂O. Then methanol was added, yielding a precipitate, which upon filtration afforded the dibutyl[5,10-dihydro-5-phenyl-1,9-di-p-toluoyldipyrrinato]tin(IV) complex as a pale yellow solid (190 mg, 6%).

Decomplexation of 10-(9-Borabicyclo[3.3.1]non-9-yl)-5-phenyl-1,9-di-p-toluoyldipyrromethane (3a-BBN→3a). A solution of 3a-BBN (0.289 g, 0.50 mmol) was in of THF (0.8 mL), was treated n-pentanol (0.2 mL). The reaction mixture was heated at reflux. After 1 h, TLC [silica, ethyl acetate/hexanes (4:1)] examination showed almost complete consumption of boron complex 3a-BBN. The mixture was concentrated to dryness and the resulting oily residue was treated with 5 mL of hexanes to afford a light pink solid residue. The mixture was heated gently under reflux for 5 min (the solid dissolved completely). The mixture was cooled affording a precipitate upon standing for few minutes. The solvent was decanted. The solid was dissolved in minimal amount of CH₂Cl₂ (˜0.2 mL), and the title compound was precipitated upon addition of hexanes. The resulting mixture was filtered on a Buchner funnel. The precipitate was collected and dried in vacuo to afford a light pink powder (75 mg, 33%). The hexanes solutions was concentrated to one fourth of the starting volume, to this minimal amount of CH₂Cl₂ (˜0.2 mL) and filtrate of the first precipitation was added, resulting a second batch of precipitate (130 mg, 57%). The combined yield (206 mg) is 90%: ¹H NMR δ 2.38 (s, 3H), 5.65 (s, 1H), 5.97-5.98 (m, 2H), 6.58-6.59 (m, 2H), 7.20 (d, J=8.0 Hz, 4H), 7.31-7.33 (m, 1H), 7.34-7.42 (m, 2H), 7.48-7.50 (m, 2H), 7.70 (d, J=8.0 Hz, 4H), 11.04 (brs, 2H); FABMS obsd 458.1994 [(M+H)⁺], calcd 458.1969 (C₃₁H₂₆N₂O₂).

5,15-Bis(4-methylphenyl)-10,20-diphenylporphyrin (8) from 3a-BBN. A sample of 3a-BBN (145 mg, 0.250 mmol) was dissolved in dry THF/methanol (3:1, 6 mL) at room temperature in a round-bottomed flask fitted with a vented rubber septum and flooded with argon. The septum was removed as needed to add NaBH₄ (946 mg, 25 mmol, 50 mol equiv) in small portions with rapid stirring. The progress of the reduction was monitored by TLC analysis [alumina, CH₂Cl₂/ethyl acetate (3:2)] of reaction aliquots. After the reaction was complete (about 40 min), the reaction mixture was poured into a stirred mixture of saturated aqueous NH₄C₁ and CH₂Cl₂. The organic phase was separated, washed with water, dried (Na₂SO⁴), and concentrated under reduced pressure to yield the dicarbinol as a foamlike solid. To the flask containing the dipyrromethane-dicarbinol (0.250 mmol assuming quantitative reduction) was added reagent grade CH₂Cl₂ (100 mL) and 1a (55 mg, 0.250 mmol). The mixture was stirred for 5 min to achieve dissolution, and then Yb(OTf)₃ (206 mg, 0.325 mmol) was added. The reaction was monitored by absorption spectroscopy [Reaction monitoring was performed by injecting a 25 μL reaction aliquot into a solution of DDQ (300 μL, 0.01 M in toluene); then 25 μL of the resulting oxidized mixture was dissolved in CH₂Cl₂/EtOH (3:1, 3 mL), and the absorption spectrum was recorded.] Then [elapsed time of 15 min after the addition of Yb(OTf)₃)] DDQ (80 mg, 0.375 mmol) was added, and the mixture was stirred at room temperature for 1 h. Then TEA was added, and the entire reaction mixture was passed through a pad of alumina (to remove quinone species) and eluted with CH₂Cl₂ until the eluant was no longer purple. The resulting porphyrin-containing solution was concentrated to give a purple solid. The solid was triturated with methanol and dried in vacuo, affording a purple crystalline solid (32 mg, 20%). The characterization data (¹H NMR, LDMS, and UV-vis spectra) were consistent with the reported values.⁷

10-(9-Borabicyclo[3.3.1]non-yl)-1-bromo-5-phenyl-9-p-toluoyldipyrromethane (9a-BBN). Following a similar procedure reported for the bromination of 1-acyldipyrromethanes,⁴ a solution of 6a-BBN (464 mg, 1.00 mmol) in 10 mL of dry THF was cooled to −78° C. under Ar. NBS (178 mg, 1.00 mmol) was added and the reaction mixture was stirred for 1 h at −78° C. Hexanes (10 mL) and water (10 mL) were added and the mixture was allowed to warm to room temperature. The organic phase was extracted with hexanes, dried (Na₂SO₄) and concentrated under reduced pressure without heating. Column chromatography [silica, hexanes/CH₂Cl₂ (1:1)] afforded a yellow orange powder (505 mg, 94%): mp 53° C. (dec.); ¹H NMR δ 0.64-0.72 (m, 2H), 1.64-1.88 (m, 6H), 1.94-2.24 (m, 6H), 2.48 (s, 3H), 5.74-5.78 (m, 1H), 5.96 (s, 1H), 6.05-6.09 (m, 1H), 6.41 (d, J=4.0 Hz, 1H), 7.18 (d, J=8.0 Hz, 2H), 7.24-7.41 (m, 6H), 7.74 (brs, 1H), 8.12 (d, J=8.0 Hz, 2H); ¹³C NMR δ 22.2, 22.9, 23.9, 25.2, 26.1, 26.4, 30.7, 30.9, 31.8, 34.57, 34.64, 44.9, 97.4, 110.2, 110.8, 118.3, 120.7, 127.4, 128.2, 128.5, 128.9, 129.9, 130.0, 133.9, 135.1, 141.6, 145.3, 151.0, 174.9; Anal. Calcd for C₃₁H₃₂BBrN₂O: C, 69.04; H, 5.98; N, 5.19. Found: C, 70.30; H, 6.38; N, 4.86.

EXPERIMENTAL 2

Investigation of the 9-Acylation of 1-Acyldipyrromethane-BR₂ Complexes. The success of the 9-acylation achieved with the use of the 1-acyldipyrromethane-BR₂ complex (6a-BBN), EtMgBr, a hindered base, and the Mukaiyama reagent (5a) prompted a series of experiments to develop further improved reaction conditions. The 1-acyldipyrromethane-BR₂ complex 6-BR₂ requires 1 equiv of EtMgBr to form the pyrrolyl-MgBr species (unlike the two equiv required for the uncomplexed 1-acyldipyrromethane 2). Two approaches can be pursued to neutralize the proton liberated upon α-acylation. (i) One equiv of a non-nucleophilic base is included in the reaction medium, as described above. (ii) A second equiv of a hindered Grignard reagent is included in the reaction medium to serve as the base, as described below.

We next examined variation of the composition of the Grignard reagent (2 mol equiv) without an other added base. The benchmark experiment with 1 mol equiv of 6a-BBN, 2 mol equiv of EtMgBr, no added base, and 1.1 mol equiv of 5a is shown in entry 1 (Table 2). A dramatic effect of Grignard reagent was observed in the series MesMgBr (8.7:1)>PhMgBr>EtMgBr>t-BuMgCl (˜0.1:1.0) (entries 2-4). Addition of MesMgBr and the Mukaiyama reagent in two batches afforded almost complete 9-acylation and no detectable 1-acyldipyrromethane-BR₂ complex (>10:1 ratio; entry 5). On the other hand, use of excess MesMgBr gave a less efficient acylation (entry 6). Thus, two equiv of MesMgBr provides for effective acylation, consistent with the notion that the second equivalent serves as the buffering agent that quenches the proton liberated upon α-acylation. TABLE 2 Effects of Grignard Reagents in the 9-Acylation of 1- Acyldipyrromethanes.^(a) Grignard Product: 6a-BBN Reagent^(b) Substrate^(d) Entry (mmol) (mmol) 5a (mmol)^(c) 3a-BBN:6a-BBN 1 0.10 EtMgBr (0.20) 0.11 2.7:1.0 2 0.10 PhMgBr (0.20) 0.11 4.4:1.0 3 0.10 MesMgBr (0.20) 0.11 8.7:1.0 4 0.10 t-BuMgCl (0.20) 0.11 0.1:1.0 5 0.10 MesMgBr 0.11 + 0.05 >10.:1.0   (0.20 + 0.05) 6 0.10 MesMgBr (0.30) 0.11 5.0:1.0 ^(a)Reactions were performed with a 1 M solution of 10-(9-borabicyclo[3.3.1]non-9-yl)-5-phenyl-1-p-toluoyldipyrromethane (6a-BBN) in THF at room temperature under argon. ^(b)The Grignard reagent was added as a 1.0 M solution in THF. ^(c)S-2-Pyridyl 4-methylbenzothioate (5a) was added as a 1 M solution in THF. ^(d)The ratio was determined by ¹H NMR spectroscopic analysis of crude reaction samples.

One experiment was performed to examine the order of addition of reactants. Addition of MesMgBr to the solution containing the 1-acyldipyrromethane-BR₂ complex and the Mukaiyama reagent gave ˜1:1 ratio of diacyl:monoacyl components. This experiment implies that MesMgBr is not wholly inert toward the Mukaiyama reagent (giving the ketone), and the pyrrolyl-MgBr species should be formed prior to adding the Mukaiyama reagent. Note that MesMgBr is expected to be largely monomeric in THF at the concentrations (0.5-1.0 M) employed in the 9-acylation.⁴¹

The success of the 9-acylation achieved with the use of the 1-acyldipyrromethane-BR₂ complex (6a-BBN), two mol equiv of MesMgBr, and the Mukaiyama reagent (5a) prompted a series of control experiments to establish whether each component was needed. The reaction of 6a-BBN, EtMgBr (2 mol equiv), and the Mukaiyama reagent 5a (Scheme 9, earlier section) afforded a 2.7:1 ratio of 1,9-diacyl to 1-acyldipyrromethane products 3a-BBN:6a-BBN (entry 1, Table 3). Replacing the Mukaiyama reagent with p-toluoyl chloride resulted in a lower ratio (entry 2). With MesMgBr, the analogous comparison of the Mukaiyama reagent versus p-toluoyl chloride gave only a slight change in product ratio, indicating the p-toluoyl chloride is as effective for acylation as the Mukaiyama reagent (entries 3 and 4). To check on the necessity of the dialkylboron complex, several acylations were performed using the uncomplexed 1-acyldipyrromethane 2a and the Mukaiyama reagent 5a. Regardless of the choice of Grignard reagent (MesMgBr or EtMgBr), very little diacyldipyrromethane was formed (entries 5 and 6). The use of 3 mol equiv of MesMgBr (as required on the basis of stoichiometry considering the two NH protons and the α-proton liberated upon acylation) gave only a slight improvement in the product ratio. TABLE 3 Essential Features for the 9-Acylation of 1-Acyldipyrromethanes. Grignard Substrate, Reagent^(b) Product: Entry mmol^(a) (mmol) RCOX (mmol)^(c) Substrate^(d) 1 6a-BBN, 0.10 EtMgBr (0.20) 5a (0.11) 2.7:1.0 2 6a-BBN, 0.10 EtMgBr (0.20) ArCOCl (0.11)^(e) 2.0:1.0 3 6a-BBN, 0.10 MesMgBr (0.20) 5a (0.11) 8.7:1.0 4 6a-BBN, 0.10 MesMgBr (0.20) ArCOCl (0.11)^(e) 8.0:1.0 5 2a, 0.10 EtMgBr (0.20) 5a (0.11) 0.3:1.0 6 2a, 0.10 MesMgBr (0.20) 5a (0.11) 0.4:1.0 7 2a, 0.10 MesMgBr (0.30) 5a (0.11) 0.8:1.0 ^(a)Reactions were performed with a 1 M solution of 10-(9-borabicyclo[3.3.1]non-9-yl)-5-phenyl-1-p-toluoyldipyrromethane (6a-BBN) or 5-phenyl-1-p-toluoyldipyrromethane (2a) in THF at room temperature under argon. ^(b)The Grignard reagent was added as a 1.0 M solution in THF. ^(c)The acylating agent was added as a 1 M solution in THF. ^(d)The ratio was determined by ¹H NMR spectroscopic analysis of crude reaction samples. ^(e)p-Toluoyl chloride.

In summary, 9-acylation is most effectively achieved with use of the dialkylboron complex of the 1-acyldipyrromethane and two mol equiv of a hindered Grignard reagent. Use of a non-hindered Grignard reagent and a hindered base, as described previously (vide supra) affords lower yields of acylation. The acylation can be achieved with an acid chloride or a Mukaiyama reagent.

Scope of Application. The generality of the 9-acylation reactions was examined with 1-acyldipyrromethane-BR₂ complexes bearing different substituents at the 1- and 5-positions. Two methods were employed, which differ only in the nature of the acylating agent. In Method A, a Mukaiyama reagent was employed (Chart 5). In method B, the corresponding acid chloride was employed.

The reaction of a 1-acyldipyrromethane-BR₂ complex was carried out at the 2-mmol scale with MesMgBr followed by addition of the acylating agent as shown in Scheme 11. The corresponding 1,9-diacyldipyrromethane-BR₂ complexes (3-BR₂) were obtained in yields of 64-92%. In most cases, the 1,9-diacyldipyrromethane-BR₂ complex was obtained simply by washing the crude solid product with a minimum amount of Et₂O followed by hexanes. In instances where the 1,9-diacyldipyrromethane-BR₂ complex was not obtained in pure form, a subsequent wash of the isolated solid with CH₂Cl₂/hexanes typically removed residual traces of any 1-acyldipyrromethane-BR₂ complex, 1-acyldipyrromethane or 1,9-diacyldipyrromethane species. On scale-up the reaction of 6a-BBN (40 mmol) with 5b gave 3b-BBN in excellent yield (91%) and purity, though the product contained a trace (<2%) of decomplexed product as estimated by TLC and ¹H NMR spectroscopy. Scheme 11

6-BR₂ R¹ R² 6a-BBN

6a-BBN

6a-BBN

6b-BBN

6b-BBN

6c-BBN

6d-BBN

6g-BBN

6a-BBu₂

6f-BBu₂

Yield 6-BR₂ R³ R₂B Product Method A Method B 6a-BBN

9-BBN 3a-BBN 79% 90% 6a-BBN

9-BBN 3b-BBN 76% 88% 6a-BBN

9-BBN 3c-BBN 82% 92% 6b-BBN

9-BBN 3d-BBN 90% 90% 6b-BBN

9-BBN 3e-BBN 80% 87% 6c-BBN

9-BBN 3f-BBN 71% 64% 6d-BBN

9-BBN 3g-BBN 76% 79% 6g-BBN

9-BBN 3h-BBN 74% 69% 6a-BBu₂

Bu₂B 3a-BBu₂ 73% 78% 6f-BBu₂

Bu₂B 3i-BBu₂ 78% 77%

The 9-acylation procedure also was applied to two 1-acyldipyrromethane-BBu₂ complexes (6a-BBu₂, 6f-BBu₂). In each case, the 9-acylation proceeded smoothly to give the resulting 1,9-diacyldipyrromethane-BR₂ complex (3a-BBu₂, 3i-BBu₂) in good yield (Scheme 11).

The treatment of a 1-acyldipyrromethane-BR₂ complex with MesMgBr followed by addition of an acid chloride gave 3a-i-BR₂ in comparable or higher yield versus that with a Mukaiyama reagent (Scheme 11). In the case of 6c-BBN with p-toluoyl chloride as the acylating agent, the product was obtained in 64% yield with no chromatography. These results show the generality of the acylation process.

9-Acylation of a 1-Acyldipyrromethane-BR₂ Complex (Method A, Mukaiyama Reagent): 10-(9-Borabicyclo[3.3.1]non-9-yl)-5-phenyl-1,9-di-p-toluoyldipyrromethane (3a-BBN). A suspension of 6a-BBN (0.92 g, 2.0 mmol) in THF (2 mL) was treated with mesitylmagnesium bromide (MesMgBr) (4.0 mL, 4.0 mmol, 1 M solution in THF), affording a clear solution that was stirred at room temperature for 5 min. Then a solution of 5a (0.50 g, 2.2 mmol) in THF (2.2 mL) was added. The mixture was stirred at room temperature for 10 min. The mixture was quenched by addition of a half-saturated aqueous solution of NH₄Cl (10 mL). Et₂O (20 mL) was added (Note 1). The organic layer was separated and washed with a saturated aqueous solution of NaHCO₃ (20 mL) followed by brine (10 mL). The organic layer was dried (Na₂SO₄) and concentrated to dryness under vacuum. The resulting brown residue was treated with a small amount of Et₂O (˜2-4 mL), affording a suspension consisting of a brown solution and a bright yellow powder. The resulting mixture was filtered on a Buchner funnel and washed with a small amount of hexanes (˜5-10 mL; Note 2). The filtered material (0.97 g, 84%, nearly pure; Note 3) was treated with CH₂Cl₂/hexanes (15 mL, 1:2) affording a suspension. The suspension was concentrated to one-fifth of the starting volume. The resulting mixture was filtered on a Buchner funnel. The precipitate was washed with hexanes to afford the title compound (0.92 g, 79%): mp 190-192° C. (dec.); ¹H NMR δ 0.68-0.74 (m, 2H), 1.66-2.28 (m, 12H), 2.42 (s, 3H), 2.48 (s, 3H), 6.00-6.02 (m, 1H), 6.10 (s, 1H), 6.46 (d, J=4.4 Hz, 1H), 6.80-6.82 (m, 1H), 7.18 (d, J=8.0 Hz, 2H), 7.25-7.38 (m, 8H), 7.77 (d, J=8.0 Hz, 2H), 8.13 (d, J=8.0 Hz, 2H), 9.10-9.12 (br, 1H); ¹³C NMR δ 21.8, 22.2, 23.9, 25.2, 26.2, 26.3, 30.8, 31.0, 34.6, 34.7, 45.1, 127.6, 128.2, 128.5, 129.1, 129.2, 129.3, 130.0, 130.1, 131.2, 135.3, 135.9, 140.5, 141.0, 142.5, 145.4, 150.1, 175.2, 184.3; FABMS obsd 579.3224, calcd 579.3183 [(M+H)⁺], (M=C₃₉H₃₉BN₂O₂); Anal. calcd for C₃₉H₃₉BN₂O₂: C, 80.96; H, 6.79; N, 4.84. Found: C, 80.81; H, 7.00; N, 4.73.

Notes: (1) The highly crystalline nature of the 1,9-diacyldipyrromethane-BR₂ complex in diethyl ether often resulted in crystallization during the organic-aqueous partition in the separatory funnel. In such cases, the workup was performed using additional THF, or alternatively, by using CH₂Cl₂. In the latter case the organic layer should be washed twice with saturated aqueous NaHCO₃ to remove the 2-mercaptopyridine.

(2) Any 2-mercaptopyridine remaining after the Et₂O/hexanes wash can be removed by washing with a minimum amount of cold methanol on a Buchner funnel.

(3) In a number of cases, analysis of the product at this stage showed inclusion of ether or THF in the crystal lattice, and traces of 1-acyldipyrromethane-BR₂ complex and uncomplexed species (1-acyldipyrromethane, 1,9-diacyldipyrromethane). When no such trace species were present, the purification could be stopped at this stage, whereupon the product was isolated as a neat solid or as a solid containing the solvent inclusion. When the remaining purification steps were performed, the product was often isolated containing other included molecules (e.g., water, CH₂Cl₂, hexane).

9-Acylation of a 1-Acyldipyrromethane-BR₂ Complex (Method B, Acid chloride): 10-(9-Borabicyclo[3.3.1]non-9-yl)-5-phenyl-1,9-di-p-toluoyldipyrromethane (3a-BBN). A suspension of 6a-BBN (0.921 g, 2.00 mmol) in THF (2 mL) was treated with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF). The mixture was stirred at room temperature for 5 min. Then a solution of p-toluoyl chloride (0.294 mL, 2.20 mmol) in THF (2.2 mL) was added. The mixture was stirred at room temperature for 10 min. The mixture was quenched by addition of a half-saturated aqueous solution of NH₄Cl (10 mL). Et₂O (20 mL) was added. The organic layer was separated and washed with saturated aqueous NaHCO₃ (20 mL) followed by brine (10 mL). The organic layer was dried (Na₂SO₄) and concentrated to dryness under vacuum. The resulting yellow residue was treated with a small amount of Et₂O (˜2-4 mL), affording a suspension consisting of a brownish yellow solution and a bright yellow powder. The resulting mixture was filtered on a Buchner funnel and washed with a small amount of hexanes (˜5-10 mL) to afford the yellow powder (1.11 g, 96%, some decomplexed 1,9-diacyldipyrromethane was present; ˜2% as estimated by ¹H NMR spectroscopy). The yellow powder was treated with CH₂Cl₂/hexanes (15 mL, 1:2) affording a suspension. The suspension was concentrated to one-fifth of the starting volume. The resulting mixture was filtered on a Buchner funnel. The precipitate was washed with hexanes to afford the title compound (1.04 g, 90%): mp 190-192° C. (dec.); ¹H NMR δ 0.67-0.73 (m, 2H), 1.66-2.27 (m, 12H), 2.42 (s, 3H), 2.48 (s, 3H), 6.00-6.01 (m, 1H), 6.10 (s, 1H), 6.45 (d, J=4.4 Hz, 1H), 6.80-6.82 (m, 1H), 7.18 (d, J=8.4 Hz, 2H), 7.25-7.38 (m, 8H), 7.77 (d, J=8.0 Hz, 2H), 8.13 (d, J=8.0 Hz, 2H), 9.07-9.11 (br, 1H); ¹³C NMR δ 21.8, 22.2, 23.9, 25.2, 26.2, 26.3, 30.8, 31.0, 34.6, 34.7, 45.1, 127.6, 128.2, 128.5, 129.1, 129.18, 129.24, 130.0, 130.1, 131.1, 135.3, 135.9, 140.5, 141.0, 142.5, 145.4, 150.0, 175.2, 184.3; FABMS obsd 579.3216 [(M+H)⁺], calcd 579.3183 (M=C₃₉H₃₉BN₂O₂). The elemental analysis calcd for the sample assuming 0.5 molar equiv of water (C₃₉H₄₀BN₂O₂₅; C, 79.72; H, 6.86; N, 4.77. Found: C, 80.13; H, 6.75; N, 4.85) is in good agreement with the observed data. Notes 1 and 3 (vide supra) also apply to this procedure.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-(p-methoxybenzoyl)-5-phenyl-1-p-toluoyldipyrromethane (3b-BBN). Following method A, reaction of 6a-BBN (0.92 g, 2.0 mmol) in THF (2.2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by 5b (0.54 g, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (0.90 g, 76%): mp 192° C. (dec.); ¹H NMR δ 0.68-0.74 (m, 2H), 1.66-2.26 (m, 12H), 2.48 (s, 3H), 3.87 (s, 3H), 6.00-6.02 (m, 1H), 6.10 (s, 1H), 6.45 (d, J=4.4 Hz, 1H), 6.80-6.82 (m, 1H), 6.96 (d, J=8.8 Hz, 2H), 7.19 (d, J=8.8 Hz, 2H), 7.25-7.39 (m, 6H), 7.89 (d, J=8.8 Hz, 2H), 8.13 (d, J=8.8 Hz, 2H), 9.12-9.20 (br, 1H); ¹³C NMR δ22.1, 23.8, 25.1, 26.2, 30.7, 31.0, 34.5, 34.6, 45.0, 55.6, 111.2, 113.7, 118.4, 119.5, 120.8, 127.5, 128.1, 128.4, 128.9, 129.9, 130.0, 131.08, 131.10, 131.3, 135.2, 140.1, 141.1, 145.3, 150.3, 162.8, 175.0, 183.4; FABMS obsd 595.3170, calcd 595.3132 [(M+H)⁺], (M=C₃₉H₃₉BN₂O₃); Anal. calcd for C₃₉H₃₉BN₂O₃: C, 78.79; H, 6.61; N, 4.71. Found: C, 78.99; H, 6.75; N, 4.70.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-(pentafluorobenzoyl)-5-phenyl-1-p-toluoyldipyrromethane (3c-BBN). Following method A, reaction of 6a-BBN (0.92 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by 5c (0.67 g, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (1.07 g, 82%): mp 195° C. (dec.); ¹H NMR δ 0.66-0.72 (m, 2H), 1.66-2.27 (m, 12H), 2.49 (s, 3H), 6.03-6.05 (m, 1H), 6.10 (s, 1H), 6.44 (d, J=4.4 Hz, 1H), 6.63-6.64 (m, 1H), 7.18 (d, J=8.0 Hz, 2H), 7.26-7.39 (m, 8H), 8.14 (d, J=8.0 Hz, 2H), 9.03-9.07 (br, 1H); ¹³C NMR δ 22.2, 23.8, 25.1, 26.2, 26.4, 30.8, 30.9, 34.5, 34.6, 45.2, 112.4, 118.5, 120.6, 122.3, 127.9, 128.0, 128.5, 129.3, 130.0, 130.1, 131.2, 135.4, 140.2, 144.1, 145.7, 148.9, 171.9, 175.7; FABMS obsd 655.2600, calcd 655.2555 [(M+H)⁺], (M=C₃₈H₃₂BF₅N₂O₂); Anal. calcd for C₃₈H₃₂BF₅N₂O₂: C, 69.74; H, 4.93; N, 4.28. Found: C, 69.97; H, 5.29; N, 4.21.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1,9-di-p-toluoyldipyrromethane (3d-BBN). Following method A, reaction of 6b-BBN (0.77 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by 5a (0.50 g, 2.20 mmol) in THF (2.2 mL) afforded a yellow suspension. The reaction mixture was filtered directly on a Buchner funnel. The filtrate (#1) was set aside. The filtered material was stirred in a half-saturated aqueous solution of NH₄Cl (10 mL) for 5 min, affording a suspension. The suspension was filtered on a Buchner funnel. The filtered material was washed with NaHCO₃ (20 mL), water (10 mL) and Et₂O (5 mL) to afford a yellow powder (0.80 mg, 80%). Filtrate #1 was worked up, affording additional material (0.10 g, 10%). The combined yield (0.90 g) is 90%: mp 215° C. (dec.); ¹H NMR δ 0.72-0.79 (m, 2H), 1.70-2.28 (m, 12H), 2.42 (s, 3H), 2.48 (s, 3H), 4.45 (s, 2H), 6.09-6.10 (m, 1H), 6.42 (d, J=4.0 Hz, 1H), 6.82-6.84 (m, 1H), 7.25 (d, J=8.0 Hz, 2H), 7.31 (d, J=4.0 Hz, 1H), 7.37 (d, J=8.0 Hz, 2H), 7.78 (d, J=8.0 Hz, 2H), 8.12 (d, J=8.0 Hz, 2H), 9.83-9.87 (br, 1H); ¹³C NMR δ 21.8, 22.2, 23.9, 25.2, 26.7, 26.4, 29.7, 31.5, 34.5, 110.5, 118.5, 120.5, 120.7, 128.2, 129.2, 129.3, 129.9, 130.0, 130.9, 135.5, 135.8, 137.6, 142.5, 145.3, 147.2, 174.7, 184.3; FABMS obsd 503.2874, calcd 503.2870 [(M+H)⁺], (M=C₃₃H₃₅BN₂O₂). The elemental analysis for the sample assuming 0.5 molar equiv of water (C₃₃H₃₆BN₂O_(2.5); C, 77.49; H, 7.09; N, 5.48. Found: C, 77.22; H, 6.92; N, 5.40) is in good agreement with the observed data.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-hexanoyl-1-p-toluoyldipyrromethane (3e-BBN). Following method A, reaction of 6b-BBN (0.77 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by 5f (0.46 g, 2.2 mmol) in THF (2.2 mL) afforded a yellow suspension. The reaction mixture was filtered directly on a Buchner funnel. The filtrate (#1) was set aside. The filtered material was stirred in a half-saturated aqueous solution of NH₄Cl (10 mL) for 5 min. The suspension was filtered on a Buchner funnel. The filtered material was washed with NaHCO₃ (20 mL), water (10 mL) and Et₂O (5 mL) to afford a yellow powder (0.70 g, 73%). Filtrate #1 after workup afforded additional material (0.07 g, 7%). The combined yield (0.77 g) is 80%: mp 190° C. (dec.); ¹H NMR δ 0.72-0.76 (m, 2H), 0.86-0.90 (m, 3H), 1.30-1.36 (m, 4H), 1.65-2.27 (m, 14H), 2.48 (s, 3H), 2.70 (t, J=8.0 Hz, 2H), 4.38 (s, 2H), 6.02-6.04 (m, 1H), 6.36 (d, J=4.0 Hz, 1H), 6.84-6.85 (m, 1H), 7.30 (d, J=4.4 Hz, 1H), 7.37 (d, J=8.0 Hz, 2H), 8.11 (d, J=8.0 Hz, 2H), 9.33-9.38 (brs, 1H); ¹³C NMR δ 14.2, 22.2, 22.7, 23.9, 25.2, 25.3, 26.7, 29.6, 31.4, 31.9, 34.5, 37.9, 109.9, 117.4, 118.4, 120.6, 128.2, 129.9, 130.2, 131.8, 135.5, 137.0, 145.2, 147.3, 174.6, 191.0; FABMS obsd 481.3199, calcd 483.3183 [(M+H)⁺], (M=C₃₁H₃₉BN₂O₂). Anal. calcd for C₃₁H₃₉BN₂O₂: C, 77.17; H, 8.15; N, 5.81. Found: C, 76.94; H, 8.13; N, 5.73.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-p-hexanoyl-5-pentyl-9-p-toluoyldipyrromethane (3f-BBN). Following method A, reaction of 6c-BBN (0.87 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.00 mL, 4.00 mmol, 1 M solution in THF) followed by 5a (0.50 g, 2.2 mmol) in THF (2 mL) afforded an orange oil. Chromatography (silica, CH₂Cl₂) afforded an off-white solid (0.78 g, 71%): mp 130° C. (dec.); ¹H NMR δ 0.54-0.63 (m, 2H), 0.82-0.86 (m, 3H), 0.92 (t, J=7.6 Hz, 3H), 1.24-1.27 (m, 6H), 1.34-1.46 (m, 6H), 1.64-2.17 (m, 14H), 2.42 (s, 3H), 2.84 (t, J=7.6 Hz, 2H), 4.56 (t, J=7.6 Hz, 1H), 6.08-6.11 (m, 1H), 6.52 (d, J=4.0 Hz, 1H), 6.77-6.80 (m, 1H), 7.09 (d, J=4.0 Hz, 1H), 7.26 (d, J=8.4 Hz, 2H), 7.76 (d, J=8.4 Hz, 2H), 9.38-9.50 (br, 1H); ¹³C NMR δ 14.1, 14.2, 21.7, 22.5, 22.6, 23.9, 25.0, 25.5, 25.9, 26.2, 27.5, 30.6, 31.1, 31.5, 31.8, 32.0, 34.1, 34.3, 36.7, 39.7, 109.5, 117.5, 117.6, 120.4, 129.1, 129.3, 130.8, 136.0, 136.7, 142.1, 142.3, 152.4, 184.4, 185.0; FABMS obsd 553.3963, calcd 553.3965 [(M+H)⁺], (M=C₃₆H₄₉BN₂O₂). Anal. calcd for C₃₆H₄₉BN₂O₂: C, 78.25; H, 8.94; N, 5.07. Found: C, 78.18; H, 9.00; N, 5.07.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-[(p-bromobenzoyl)-1-(p-methoxybenzoyl)-5-(p-methoxyphenyl)dipyrromethane (3g-BBN). Following method A, reaction of 6d-BBN (1.01 g, 2.0 mmol) in THF (8 mL, owing to solubility limitations even after adding the Grignard reagent) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by 5e (0.65 g, 2.2 mmol) in THF (8.8 mL) afforded a yellow powder (1.05 g, 76%): mp 129-131° C. (dec.); ¹H NMR δ 0.64-0.70 (m, 2H), 1.68-2.26 (m, 12H), 3.79 (s, 3H), 3.93 (s, 3H), 5.99-6.01 (m, 1H), 6.03 (s, 1H), 6.43 (d, J=4.4 Hz, 1H), 6.76-6.77 (m, 1H), 6.85 (d, J=8.0 Hz, 2H), 7.06 (d, J=8.0 Hz, 2H), 7.09 (d, J=8.0 Hz, 2H), 7.31 (d, J=4.0 Hz, 1H), 7.59 (d, J=8.0 Hz, 2H), 7.72 (d, J=8.0 Hz, 2H), 8.22 (d, J=8.0 Hz, 2H), 9.11-9.16 (brs, 1H); ¹³C NMR δ 23.9, 25.2, 26.2, 30.8, 31.0, 34.6, 34.7, 44.3, 55.5, 55.9, 114.4, 114.8, 117.9, 120.3, 120.5, 123.4, 129.5, 130.7, 131.7, 132.2, 133.1, 134.8, 137.3, 142.0, 149.6, 158.9, 164.7, 174.5, 183.2; FABMS obsd 689.2170, calcd 689.2188 [(M+H)⁺], (M=C₃₉H₃₈BBrN₂O₄). Anal. calcd for C₃₉H₃₈BBrN₂O₄: C, 67.94; H, 5.56; N, 4.06. Found: C, 68.05; H, 5.66; N, 4.09.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(p-bromobenzoyl)-9-[(p-iodobenzoyl)-5-[p-(trimethylsilylethynyl)phenyl]dipyrromethane (3h-BBN). Following method A, reaction of 6g-BBN (1.2 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.00 mL, 4.00 mmol, 1 M solution in THF) followed by 5d (0.75 g, 2.2 mmol) in THF (4 mL) afforded an orange oil. Chromatography [silica, CH₂Cl₂/hexanes (1:1)→CH₂Cl₂/hexanes (2:1) afforded a yellow-orange solid (1.26 g, 74%): mp 139° C. (dec.); ¹H NMR δ 0.25 (s, 9H), 0.64-0.74 (m, 2H), 1.65-2.24 (m, 12H), 5.95-6.02 (m, 1H), 6.10 (s, 1H), 6.43 (d, J=4.4 Hz, 1H), 6.75-6.78 (m, 1H), 7.04 (d, J=8.0 Hz, 2H), 7.31 (d, J=4.4 Hz, 1H), 7.36 (d, J=8.0 Hz, 2H), 7.51 (d, J=8.0 Hz, 2H), 7.72 (d, J=8.0 Hz, 2H), 7.80 (d, J=8.0 Hz, 2H), 8.06 (d, J=8.0 Hz, 2H), 9.76-9.84 (br, 1H); ¹³C NMR δ 0.18, 23.6, 25.0, 26.2, 30.6, 31.0, 34.4, 34.6, 44.9, 95.0, 99.4, 104.8, 111.8, 118.7, 120.6, 121.5, 122.3, 128.1, 129.4, 129.5, 130.8, 131.0, 131.1, 132.4, 132.7, 135.2, 137.5, 137.6, 140.6, 141.4, 150.8, 173.6, 183.6; FABMS obsd 851.1362, calcd 851.1337 [(M+H)⁺], (M=C₄₂H₄,BBrN₂O₂Si). Anal. calcd for C₄₂H₄₁BBrN₂O₂Si: C, 59.24; H, 4.85; N, 3.29. Found: C, 59.51; H, 4.98; N, 3.31.

10-(Dibutylboryl)-5-phenyl-1,9-d]-p-toluoyldipyrromethane (3a-BBu₂). Following method A, reaction of 6a-BBu₂ (0.85 g, 1.83 mmol) in THF (1.8 mL) with MesMgBr (3.66 mL, 3.66 mmol, 1 M solution in THF) followed by 5a (0.46 g, 2.01 mmol) in THF (2 mL) afforded a brown oil. After general workup, the brown residue was dissolved in a 5 mL solution of Et₂O/hexanes (2:3). After a few minutes, a brownish yellow precipitate was observed. The resulting mixture was filtered on a Buchner funnel and washed with a small amount of hexanes (3-5 mL) to afford a yellow powder (0.78 g, 73%): mp 164° C. (dec.); ¹H NMR δ 0.48-0.71 (m, 10H), 0.78-1.13 (m, 8H), 2.42 (s, 3H), 2.48 (s, 3H), 5.67 (s, 1H), 6.03-6.05 (m, 1H), 6.45 (d, J=4.0 Hz, 1H), 6.80-6.82 (m, 1H), 7.24-7.29 (m, 6H), 7.33 (d, J=7.6 Hz, 2H), 7.37 (d, J=7.6 Hz, 2H), 7.76 (d, J=8.0 Hz, 2H), 8.12 (d, J=8.0 Hz, 2H), 9.06-9.12 (br, 1H); ¹³C NMR δ 14.3, 14.4, 21.8, 22.2, 22.6, 26.2, 26.2, 27.1, 27.4, 44.3, 111.0, 117.9, 119.1, 120.0, 127.7, 127.9, 128.6, 129.1, 129.1, 130.10, 130.12, 131.0 134.4, 135.9, 140.1, 140.3, 142.4, 145.7, 148.1, 177.1, 184.3; FABMS obsd 583.3536, calcd 583.3496 [(M+H)⁺], (M=C₃₉H₁₃BN₂O₂).

10-(Dibutylboryl)-1-(p-iodobenzoyl)-5-mesityl-9-p-toluoyldipyrromethane (3i-BBu₂). Following method A, reaction of 6f-BBu₂ (1.23 g, 2.00 mmol) in THF (2 mL) with MesMgBr (4.00 mL, 4.00 mmol, 1 M solution in THF) followed by 5a (0.50 g, 2.2 mmol) in THF (4.4 mL) afforded a brown oil. Chromatography [silica, CH₂Cl₂/hexanes (1:2)] afforded a yellow solid (1.15 g, 78%): mp 80-82° C. (dec.); ¹H NMR δ −0.08-−0.03 (m, 1H), 0.29-0.71 (m, 7H), 0.72-0.97 (m, 8H), 1.12-1.19 (m, 2H), 2.15 (s, 6H), 2.27 (s, 3H), 2.42 (s, 3H), 5.94 (s, 1H), 5.99-6.00 (m, 1H), 6.45 (d, J=4.4 Hz, 1H), 6.81-6.83 (m, 1H), 6.85 (s, 2H), 7.19 (d, J=4.0 Hz, 1H), 7.27 (d, J=8.0 Hz, 2H), 7.78 (d, J=8.0 Hz, 2H), 7.89 (d, J=8.0 Hz, 2H), 7.93 (d, J=8.0 Hz, 2H), 9.03-9.11 (br, 1H); ¹³C NMR δ 14.3 14.4, 20.9, 21.2, 21.7, 21.8, 26.2, 27.2, 27.6, 40.2, 102.2, 11.2, 117.4, 120.1, 122.1, 129.2, 129.3, 129.9, 130.6, 130.8, 131.0, 133.5, 135.5, 135.9, 137.2, 137.5, 138.6, 139.2, 142.4, 150.1, 175.5, 184.1; FABMS obsd 737.2812, calcd 737.2775 [(M+H)⁺], (M=C₄₁H₄₆BIN₂O₂); Anal. calcd for C₄₁H₄₆BIN₂O₂: C, 66.86; H, 6.30; N, 3.80. Found: C, 67.24; H, 6.37; N, 3.74.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-(p-methoxybenzoyl)-5-phenyl-1-p-toluoyldipyrromethane (3b-BBN). Following method B, reaction of 6a-BBN (0.92 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.00 mmol, 1 M solution in THF) followed by addition of p-anisoyl chloride (0.30 mL, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (1.05 g, 88%) with satisfactory characterization data (mp, and ¹H NMR) as reported for method A. The elemental analysis for the sample assuming 0.5 molar equiv of water (C₃₉H₄₀BN₂O_(3.5); C, 77.61; H, 6.68; N, 4.64. Found: C, 77.33; H, 6.62; N, 4.54) is in good agreement with the observed data.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-(pentafluorobenzoyl)-5-phenyl-1-p-toluoyldipyrromethane (3c-BBN). Following method B, reaction of 6a-BBN (0.92 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of pentafluorobenzoyl chloride (0.32 mL, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (1.21 g, 92%) with satisfactory characterization data (mp, ¹H NMR and elemental analysis) as reported for method A.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1,9-d]-p-toluoyldipyrromethane (3d-BBN). Following method B, reaction of 6b-BBN (0.77 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-toluoyl chloride (0.29 mL, 2.2 mmol) in THF (2.2 mL) and the workup procedure described for 3d-BBN (method A) afforded a yellow powder (0.90 g, 90%) with satisfactory characterization data (mp and ¹H NMR) as reported for method A. The elemental analysis for the sample assuming 0.5 molar equiv of water (C₃₃H₃₆BN₂O_(2.5); C, 77.49; H, 7.09; N, 5.48. Found: C, 77.53; H, 7.04; N, 5.36) is in good agreement with the observed data.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-hexanoyl-1-p-toluoyldipyrromethane (3e-BBN). Following method B, reaction of 6b-BBN (0.77 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of hexanoyl chloride (0.30 mL, 2.2 mmol) in THF (2.2 mL) and the workup procedure for 3e-BBN (method A) afforded a yellow powder (0.84 g, 87%) with satisfactory characterization data (mp and ¹H NMR) as reported for method A. The elemental analysis for the sample assuming 0.5 molar equiv of water (C₃₁H₄₀BN₂O_(2.5); C, 75.76; H, 8.20; N, 5.70. Found: C, 75.38; H, 8.03; N, 5.65) is in good agreement with the observed data.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-p-hexanoyl-5-pentyl-9-p-toluoyldipyrromethane (3f-BBN). Following method B, reaction of 6c-BBN (0.87 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-toluoyl chloride (0.30 mL, 2.2 mmol) in THF (2.2 mL) afforded an off-white powder (0.70 g, 64%) with satisfactory characterization data (mp, ¹H NMR and elemental analysis) as reported for method A.

10-(9-Borabicyclo[3.3.1]non-9-yl)-9-(p-bromobenzoyl)-1-(p-methoxybenzoyl)-5-(p-methoxyphenyl)dipyrromethane (3g-BBN). Following method B, reaction of 6d-BBN (1.01 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-bromobenzoyl chloride (0.48 g, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (1.08 g, 79%) with satisfactory characterization data (mp, ¹H NMR and elemental analysis) as reported for method A.

10-(9-Borabicyclo[3.3.1]non-9-yl)-1-(p-bromobenzoyl)-9-(p-iodobenzoyl)-5-[p-(trimethylsilylethynyl)phenyl]dipyrromethane (3h-BBN). Following method B, reaction of 6g-BBN (1.24 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-iodobenzoyl chloride (0.57 g, 2.2 mmol) in THF (2.2 mL) afforded a yellow-orange powder (1.17 g, 69%) with satisfactory characterization data (mp, ¹H NMR and elemental analysis) as reported for method A.

10-(Dibutylboryl)-5-phenyl-1,9-d]-p-toluoyldipyrromethane (3a-BBu₂). Following method B, reaction of 6a-BBu₂ (0.93 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-toluoyl chloride (0.30 mL, 2.2 mmol) in THF (2.2 mL) afforded an off-white powder (0.91 g, 78%) with satisfactory characterization data (mp, ¹H NMR and elemental analysis) as reported for method A.

10-(Dibutylboryl)-1-(p-iodobenzoyl)-5-mesityl-9-p-toluoyldipyrromethane (3i-BBu₂). Following method B, reaction of 6f-BBu₂ (1.48 g, 2.0 mmol) in THF (2 mL) with MesMgBr (4.0 mL, 4.0 mmol, 1 M solution in THF) followed by addition of p-toluoyl chloride (0.30 mL, 2.2 mmol) in THF (2.2 mL) afforded a yellow powder (1.14 g, 77%) with satisfactory characterization data (mp, ¹H NMR and FABMS) as reported for method A.

Removal of Solvent of Inclusion in Samples of 1,9-Diacyldipyrromethane-BR₂ Complexes. A number of samples of 1,9-diacyldipyrromethane-BR₂ complexes were found upon ¹H NMR analysis to include solvent (e.g., diethyl ether, THF) in the crystal lattice. To remove the solvent, the solid sample was dissolved in a minimum amount of CH₂Cl₂. The solution was treated with hexanes. The solution was concentrated to dryness in vacuo. The residue in the evaporation flask was triturated with hexanes 2-3 times and the solvents were again removed in vacuo. The resulting ¹H NMR spectrum typically showed the absence of peaks due to the ethereal solvent, but did show the presence of a peak due to hexane or CH₂Cl₂. Any peak due to water was not unambiguously ascribable to that from solvent of inclusion; however, a number of samples upon elemental analysis afforded satisfactory results upon assuming the presence of 1 molecule of water per two molecules of 1,9-diacyldipyrromethane-BR₂ complex.

REFERENCES

-   (1) Rao, P. D. et al., J. Org. Chem. 2000, 65, 7323-7344. -   (2) Rao, P. D. et al., J. Org. Chem. 2000, 65, 1084-1092. -   (3) Littler, B. J. et al., J. Org. Chem. 1999, 64, 2864-2872. -   (4) Taniguchi, M. et al., J. Org. Chem. 2001, 66, 7342-7354. -   (5) (a) Guilard, R. et al., Org. Lett. 2002, 4, 4491-4494. (b)     Gryko, D. T. Eur. J. Org. Chem. 2002, 1735-1743. (c) Decréau, R. A.     et al., Tetrahedron Lett. 2003, 44, 3323-3327. (d) Gryko, D. T. et     al., J. Porphyrins Phthalocyanines 2003, 7, 239-248. -   (6) Lee, C.-H. et al., Tetrahedron 1995, 51, 11645-11672. -   (7) Tamaru, S.-I. et al., J. Org. Chem. 2004, 69, 765-777. -   (8) Mehta, P. et al., J. Indian Chem. Soc. 1984, LXI, 571-572. -   (9) Hübler, K. et al., Anorg. Allg. Chem. 2000, 626, 1224-1236. -   (10) Dawson, D. M. et al., J. Chem. Soc. Dalton Trans. 2000,     459-466. -   (11) Adams, H. et al., J. Chem. Soc. Dalton Trans. 1986, 693-699. -   (12) Bacchi, A. et al., J. Inorg. Biochem. 1998, 69, 101-112. -   (13) Treibs, A. et al., Liebigs Ann. Chem. 1968, 718, 208-223. -   (14) (a) Wagner, R. W. et al., Pure Appl. Chem. 1996, 68, 1373-1380.     Corrigendum: Wagner, R. W.; Lindsey, J. S. Pure Appl. Chem. 1998, 70     (8), p. i. (b) Burghart, A. et al., J. Org. Chem. 1999, 64,     7813-7819. (c) Kim, H. et al., Chem. Commun. 1999, 1889-1890. (d)     Burghart, A. et al., Chem. Commun. 2000, 2203-2204. (e) Chen, J. et     al., J. Org. Chem. 2000, 65, 2900-2906. (f) Ambroise, A. et al., J.     Org. Chem. 2002, 67, 3811-3826. (g) Gabe, Y. et al., J. Am. Chem.     Soc. 2004, 126, 3357-3367. -   (15) Chen, J. et al., Tetrahedron Lett. 2000, 41, 2303-2307. -   (16) Minkin, V. I. et al., Russ. J. Coord. Chem. 1998, 24,152-161. -   (17) Köster, R. et al., Liebigs Ann. Chem. 1968, 720, 32-57. -   (18) Bellut, H. et al., Liebigs Ann. Chem. 1970, 738, 86-96. -   (19) Bellut, H. et al., Synth. Inorg. Metal-Org. Chem. 11971, 83-91. -   (20) Kerschl, S. et al., J. Chem. Soc., Chem. Commun. 1986, 403-404. -   (21) Wrackmeyer, B. et al., J. Organomet. Chem. 1997, 541, 97-107. -   (22) Wrackmeyer, B. et al., J. Organomet. Chem. 1997, 534, 181-186. -   (23) Wrackmeyer, B. et al., J. Organomet. Chem. 1997, 534, 207-211. -   (24) Wrackmeyer, B. et al., J. Organomet. Chem. 1997, 545-546,     297-308. -   (25) Wrackmeyer, et al., J. Organomet. Chem. 1997, 552, 247-254. -   (26) (a) Cornelissen-Gude, C.; Retting, W. J. Phys. Chem. A 1999,     103, 4371-4377. (b) Kehr, G. et al., G. Chem. Eur. J. 2000, 6,     258-266. -   (27) Tomizaki, K.-Y. et al., Tetrahedron 2004, 60, 2011-2023. -   (28) Wrackmeyer, B. Ann Rep. NMR Spectroscopy 1988, 20, 61-203. -   (29) English, R. B. et al., Acta Cryst. 1980, B36, 1136-1141. -   (30) Araki, M. et al., Bull. Chem. Soc. Jpn. 1974, 47, 1777-1780. -   (31) Laha, J. K. et al., Org. Process Res. Dev. 2003, 7, 799-812. -   (32) Cho, W.-S. et al., J. Org. Chem. 1999, 64, 7890-7901. -   (33) Geier, G. R. et al., J. Porphyrins Phthalocyanines 2001, 5,     810-823. -   (34) Bar-Haim, G.; Kol, M. J. Org. Chem. 1997, 62, 6682-6683. -   (35) Bar-Haim, G.; Kol, M. Tetrahedron Lett. 1998, 39, 2643-2644. -   (36) (a) Fenyo, D. et al., J. Porphyrins Phthalocyanines 1997, 1,     93-99. (b) Srinivasan, N. et al., J. Porphyrins Phthalocyanines     1999, 3, 283-291. -   (37) Araki, M. et al., Bull. Chem. Soc. Jpn. 1974, 47, 1777-1780. -   (38) Fraser, R. R.; Mansour, T. S. J. Org. Chem. 1984, 49,     3442-3443. -   (39) Yang, K.-C. et al., J. Organomet. Chem. 2002, 648, 176-187. -   (40) Nicolaou, K. C. et al., Tetrahedron Lett. 1981, 22, 4647-4650. -   (41) Walker F. W.; Ashby, E. C. J. Am. Chem. Soc. 1969, 91,     3845-3850.

The foregoing is illustrative of the present invention, and is not to be construed as limiting thereof. The invention is defined by the following claims, with equivalents of the claims to be included therein. 

1. A method of making a metal complex, comprising: (a) providing a 1-monoacyldipyrromethane; and then (b) combining said 1-monoacyldipyrromethane with a compound of the formula R¹R²MX, wherein: M is boron, R¹ and R² are each independently selected from the group consisting of alkyl, alkenyl, alkynyl, and aryl, each of which can be unsubstituted or substituted one or more times with a substituent selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylcarbonyl, alkylcarbonyloxy, alkylsulfinyl, alkylsulfonyl, alkylthio, halo, cyano, nitro, sulfo, oxo, formyl, azido, and carbamoyl; and X is an anion leaving group; to produce a metal complex of the formula DMR₂, wherein DH is said 1-monoacyldipyrromethane.
 2. The method of claim 1, wherein said combining step is carried out by combining a mixture containing said 1-monoacyldipyrromethane with said compound of the formula R¹R²MX.
 3. The method of claim 1 wherein said combining step is carried out in a solution and said metal complex is solubilized or suspended in said solution, said method further comprising the steps of: (c) combining said metal complex with a hindered alkyl amine base in an organic solvent to form a solid comprising said metal complex; and then (d) separating said solid from said organic solvent.
 4. The method of claim 3, wherein said hindered alkyl amine base is selected from the group consisting of triethylamine, diisopropylethylamine, and triphenylamine.
 5. The method of claim 3, wherein said solvent comprises dichloromethane.
 6. The method of claim 1, further comprising the step of (c) decomplexing said 1-monoacyldipyrromethane from said metal complex by combining said metal complex with an hydroxide, an alcohol, water, or combination thereof.
 7. The method of claim 1, wherein said compound of formula R¹R²MX is immobilized on a solid support, said method further comprising the step of: (c) releasing said 1-monoacyldipyrromethane complex from said solid support.
 8. A 1-monoacyldipyrromethane-boron complex of the formula DMR¹R², wherein: DH is a 1-monoacyldipyrromethane, M is boron, and R¹ and R² are each independently selected from the group consisting of alkyl, alkenyl, alkynyl, and aryl, each of which can be unsubstituted or substituted one or more times with a substituent selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylcarbonyl, alkylcarbonyloxy, alkylsulfinyl, alkylsulfonyl, alkylthio, halo, cyano, nitro, sulfo, oxo, formyl, azido, and carbamoyl.
 9. The 1-monoacyldipyrromethane-boron complex of claim 8 in solid form.
 10. The 1-monoacyldipyrromethane-boron complex of claim 8 in crystal solid form.
 11. A method of making a porphyrin, comprising: providing a 1-monoacyldipyrromethane-boron complex according to claim 8, and then reducing said 1-monoacyldipyrromethane in said complex without prior decomplexation of said boron to produce said porphyrin.
 12. The method of claim 11, wherein said reducing step is carried out with NaBH₄ in an organic solvent.
 13. A method of making a 1,9-diacyldipyrromethane metal complex, comprising: providing a 1-monoacyldipyrromethane-boron complex according to claim 8, then acylating said 1-monoacyldipyrromethane in said complex at the 9 position to produce said 1,9-diacyldipyrromethane metal complex.
 14. The method of claim 13, wherein said acylating step is carried out with an acylating agent in the presence of a Grignard reagent, and optionally a base, to produce said 1,9-diacyldipyrromethane metal complex.
 15. The method of claim 13, wherein said acylating step is carried out with an acid halide acylating agent in the presence of a Grignard reagent, and optionally a base, to produce said 1,9-diacyldipyrromethane metal complex.
 16. The method of claim 13, wherein said acylating step is carried out with an active ester acylating agent in the presence of a Grignard reagent, and optionally a base, to produce said 1,9-diacyldipyrromethane metal complex.
 17. The method of claim 13, wherein said acylating step is carried out with a pyridyl thioate Mukaiyama reagent in the presence of a Grignard reagent, and optionally a base, to produce said 1,9-diacyldipyrromethane metal complex.
 18. The method of claim 14, wherein the conjugate acid of said base has a pK_(a) greater than that of the conjugate acid of the nonacylated pyrrole group in said 1-monoacyldipyrromethane.
 19. The method of claim 14, wherein said base is the deprotonated form of a compound selected from the group consisting of tetraalkylpiperidine, dicycloalkylamine, and disilazane.
 20. The method of claim 14, wherein said base is present and added as a preformed base.
 21. The method of claim 14, wherein said base is formed in situ, and wherein the conjugate acid of said base has a pK_(a) less than that of the conjugate acid of said Grignard reagent.
 22. The method of claim 14, wherein said base is present or absent, and wherein said Grignard reagent is a hindered Grignard reagent.
 23. The method of claim 13, further comprising the step of: decomplexing said 1,9-diacyldipyrromethane from said metal complex by combining said metal complex with an hydroxide, an alcohol, water, or combination thereof to form a product.
 24. The method of claim 23, further comprising the steps of: combining said product with a compound of the formula R¹R²M′X′₂ in the presence of a base, where M′ is Sn, Si, Ge, or Pb, and X′ is halo, OAc, acac or OTf, to form a metal complex of the formula DM′R¹R² in said mixed reaction product, wherein DH₂ is said 1,9-diacyldipyrromethane; and then separating said metal complex from said mixed reaction product.
 25. The method of claim 13, further comprising the steps of: reducing said metal complex with a reducing agent to form a diol from said 1,9-diacyldipyrromethane; and then condensing said diol with a dipyrromethane to form a porphyrin ring compound therefrom.
 26. The method of claim 25, wherein said reducing agent is NaBH₄.
 27. A method of making a compound useful as a chlorin eastern half, comprising: providing a 1-monoacyldipyrromethane-boron complex according to claim 8, and then substituting said 1-monoacyldipyrromethane in said complex of claim 11 at the 9 postion with halo, alkoxy or acetoxy to produce a 1-acyl-9-substituted DIpyrromethane boron complex useful as a chlorin eastern half.
 28. The method of claim 27, wherein said substituting step is a halogenating step.
 29. The method of claim 28, further comprising the steps of: forming a carbinol reduction product of said 1-acyl-9-substituted dipyrromethane boron complex; then condensing said carbinol reduction product with a chlorin western half in an organic solvent in the presence of an acid to form a condensation product; and then oxidatively cyclizing said condensation product to produce a chlorin.
 30. The method of claim 29, wherein said oxidatively cyclizing step is carried out in an organic solvent in the presence of a base, an oxidant and a metal salt. 